uuid,question,answer,source,Date,Responder ,SQL Category,bio_category,Notes,Template #s,Template Questions ,,,,,
Q1,Is TUBB a druggable gene?,"There are currently 20 approved drugs which target TUBB, indicating that it is a druggable gene.  ",DrugGeneTargets_v1_974                                                                                                                                                                                                                                                                                              DrugGeneTargets_v1_6261                                                                                                                                                                                                                                                                                             DrugGeneTargets_v1_4166                                                                                                                                                                                                                                                                                            DrugGeneTargets_v1_3175                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_5604                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_3353                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_6364                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_4743                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_2339                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_762                                                                                                                                                                                                                                                                                              DrugGeneTargets_v1_2013                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_1267                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_2177                                                                                                                                                                                                                                                                                            DrugGeneTargets_v1_5140                                                                                                                                                                                                                                                                                             DrugGeneTargets_v1_2330                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_5756                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5757                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_1084                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_1085                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_560                                                                                                                                                                                                                                                                                               DrugGeneTargets_v1_561                                                                                                                                                                                                                                                                                            DrugGeneTargets_v1_4157                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_4158                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_2794                                                                                                                                                                                                                                                                                       DrugGeneTargets_v1_2795                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_1871                                                                                                                                                                                                                                                                                              DrugGeneTargets_v1_1872,7/17/2024,Maya,Select; Count,Drug meta,,,Is [approvedSymbol] a druggable gene?,"There are currently {number_of_approved_drugs} approved drugs which target {approvedSymbol}, indicating that it is a druggable gene.","There are currently no approved drugs targeting {approvedSymbol}, but there are {number_of_potential_targets (not approved yet)} potential targets indicating that it may be a druggable gene.","There are currently no approved drugs or potential targets for {approvedSymbol}, suggesting that it is not currently considered a druggable gene.","There was one approved drug that targeted {approvedSymbol} but it has been withdrawn, suggesting complications in its druggability.","There were {number_of_withdrawn_drugs} drugs that targeted {approvedSymbol} but they have been withdrawn, suggesting complications in its druggability."
Q2,What are the allele frequencies of variant rs12206095 in PD?,"In the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs12206095 has an alternate allele (A) frequency of 0.0317, and a reference allele (G) frequency of 0.9683.",PDno23andme_full_gene_notext_198,7/22/2024,Maya,Select; Calculation,Snp disease relations ,,,What are the allele frequencies of variant x in y?,,,,,
Q3,What are the allele frequencies of variant rs61769339 in AD?,"In GWAS summary statistics for AD from Bellenguez (2022), single nucleotide polymorphism rs61769339 has an alternate allele (A) frequency of 0.1105 and reference
allele (G) frequency of 0.8895.",AD_combo_gene_notext_UUID_7,7/22/2024,Maya,Select; Calculation,Snp disease relations ,,,,,,,,
Q4,What drugs target the gene ACACA? ,"There are no FDA approved drugs targeting the gene ACACA. However the following drugs are currently in various clinical trial stages: Firsocostat,
Pf-05175157, Clesacostat, and Olumacostat Glasaretil. ","DrugGeneTargets_v1_2565
DrugGeneTargets_v1_1425
DrugGeneTargets_v1_2356
DrugGeneTargets_v1_2233",8/7/2024,Maya,Select; Group By,Drug Gene relations,,,What drugs target the gene x? ,,,,,
Q5,Is Rotigotine approved to treat AD?,"Rotigotine has not been approved by the FDA as a treatment for Alzheimer's disease (AD), but it is currently undergoing evaluation in clinical trials for this purpose.","DrugTargetsIndication121923_text_201120
DrugTargetsIndication121923_text_200835
DrugTargetsIndication121923_text_201210
DrugTargetsIndication121923_text_201220
DrugTargetsIndication121923_text_200920
DrugTargetsIndication121923_text_201135
DrugTargetsIndication121923_text_201305
DrugTargetsIndication121923_text_200720
DrugTargetsIndication121923_text_200785
DrugTargetsIndication121923_text_201100
DrugTargetsIndication121923_text_201255
DrugTargetsIndication121923_text_200875
DrugTargetsIndication121923_text_200925
DrugTargetsIndication121923_text_200820
DrugTargetsIndication121923_text_200840
DrugTargetsIndication121923_text_201275
DrugTargetsIndication121923_text_201335
DrugTargetsIndication121923_text_200725
DrugTargetsIndication121923_text_200845
DrugTargetsIndication121923_text_200910
DrugTargetsIndication121923_text_201105
DrugTargetsIndication121923_text_200805
DrugTargetsIndication121923_text_200850
DrugTargetsIndication121923_text_200870
DrugTargetsIndication121923_text_200990
DrugTargetsIndication121923_text_201250
DrugTargetsIndication121923_text_200710
DrugTargetsIndication121923_text_200810
DrugTargetsIndication121923_text_201055
DrugTargetsIndication121923_text_201215
DrugTargetsIndication121923_text_201285
DrugTargetsIndication121923_text_200750
DrugTargetsIndication121923_text_201075
DrugTargetsIndication121923_text_200745
DrugTargetsIndication121923_text_200800
DrugTargetsIndication121923_text_200980
DrugTargetsIndication121923_text_201175
DrugTargetsIndication121923_text_200970
DrugTargetsIndication121923_text_201005
DrugTargetsIndication121923_text_201035
DrugTargetsIndication121923_text_201155
DrugTargetsIndication121923_text_201205
DrugTargetsIndication121923_text_201110
DrugTargetsIndication121923_text_201270
DrugTargetsIndication121923_text_200935
DrugTargetsIndication121923_text_200865
DrugTargetsIndication121923_text_201160
DrugTargetsIndication121923_text_201000
DrugTargetsIndication121923_text_201170
DrugTargetsIndication121923_text_201070
DrugTargetsIndication121923_text_201085
DrugTargetsIndication121923_text_201115
DrugTargetsIndication121923_text_201140
DrugTargetsIndication121923_text_201080
DrugTargetsIndication121923_text_200740
DrugTargetsIndication121923_text_200790
DrugTargetsIndication121923_text_200955
DrugTargetsIndication121923_text_201125
DrugTargetsIndication121923_text_200900
DrugTargetsIndication121923_text_200815
DrugTargetsIndication121923_text_200930
DrugTargetsIndication121923_text_200730
DrugTargetsIndication121923_text_200760
DrugTargetsIndication121923_text_201030
DrugTargetsIndication121923_text_201050
DrugTargetsIndication121923_text_200860
DrugTargetsIndication121923_text_200915
DrugTargetsIndication121923_text_201180
DrugTargetsIndication121923_text_201195
DrugTargetsIndication121923_text_201330
DrugTargetsIndication121923_text_200770
DrugTargetsIndication121923_text_200780
DrugTargetsIndication121923_text_200985
DrugTargetsIndication121923_text_201165
DrugTargetsIndication121923_text_201020
DrugTargetsIndication121923_text_201065
DrugTargetsIndication121923_text_201190
DrugTargetsIndication121923_text_200765
DrugTargetsIndication121923_text_201200
DrugTargetsIndication121923_text_200975
DrugTargetsIndication121923_text_201145
DrugTargetsIndication121923_text_201235
DrugTargetsIndication121923_text_201295
DrugTargetsIndication121923_text_200755
DrugTargetsIndication121923_text_201095
DrugTargetsIndication121923_text_200885
DrugTargetsIndication121923_text_200890
DrugTargetsIndication121923_text_201245
DrugTargetsIndication121923_text_200905
DrugTargetsIndication121923_text_201280
DrugTargetsIndication121923_text_201320
DrugTargetsIndication121923_text_200880
DrugTargetsIndication121923_text_200855
DrugTargetsIndication121923_text_200945
DrugTargetsIndication121923_text_200960
DrugTargetsIndication121923_text_200950
DrugTargetsIndication121923_text_201015
DrugTargetsIndication121923_text_201130
DrugTargetsIndication121923_text_200775
DrugTargetsIndication121923_text_201315
DrugTargetsIndication121923_text_200715
DrugTargetsIndication121923_text_200795
DrugTargetsIndication121923_text_201060
DrugTargetsIndication121923_text_201290
DrugTargetsIndication121923_text_200735
DrugTargetsIndication121923_text_201185
DrugTargetsIndication121923_text_201300
DrugTargetsIndication121923_text_200825
DrugTargetsIndication121923_text_200830
DrugTargetsIndication121923_text_200965
DrugTargetsIndication121923_text_201010
DrugTargetsIndication121923_text_201025
DrugTargetsIndication121923_text_201150
DrugTargetsIndication121923_text_201265
DrugTargetsIndication121923_text_201310
DrugTargetsIndication121923_text_201325
DrugTargetsIndication121923_text_200895
DrugTargetsIndication121923_text_201225
DrugTargetsIndication121923_text_201045
DrugTargetsIndication121923_text_201090
DrugTargetsIndication121923_text_201230
DrugTargetsIndication121923_text_201260
DrugTargetsIndication121923_text_201040
DrugTargetsIndication121923_text_200940
DrugTargetsIndication121923_text_200995
DrugTargetsIndication121923_text_201240",7/22/2024,Maya,,Drug Disease relations; Drug meta,,,Is x approved to treat y?,,,,,
Q6,What genes does Rotigotine target when it's used to treat AD?,"Rotigotine has not been approved by the FDA as a treatment for Alzheimer's disease (AD), but it is currently undergoing evaluation in clinical trials for this purpose. However, the proposed gene targets are DRD2, DRD3, and DRD4.","DrugTargetsIndication121923_text_201120
DrugTargetsIndication121923_text_200835
DrugTargetsIndication121923_text_201210
DrugTargetsIndication121923_text_201220
DrugTargetsIndication121923_text_200920
DrugTargetsIndication121923_text_201135
DrugTargetsIndication121923_text_201305
DrugTargetsIndication121923_text_200720
DrugTargetsIndication121923_text_200785
DrugTargetsIndication121923_text_201100
DrugTargetsIndication121923_text_201255
DrugTargetsIndication121923_text_200875
DrugTargetsIndication121923_text_200925
DrugTargetsIndication121923_text_200820
DrugTargetsIndication121923_text_200840
DrugTargetsIndication121923_text_201275
DrugTargetsIndication121923_text_201335
DrugTargetsIndication121923_text_200725
DrugTargetsIndication121923_text_200845
DrugTargetsIndication121923_text_200910
DrugTargetsIndication121923_text_201105
DrugTargetsIndication121923_text_200805
DrugTargetsIndication121923_text_200850
DrugTargetsIndication121923_text_200870
DrugTargetsIndication121923_text_200990
DrugTargetsIndication121923_text_201250
DrugTargetsIndication121923_text_200710
DrugTargetsIndication121923_text_200810
DrugTargetsIndication121923_text_201055
DrugTargetsIndication121923_text_201215
DrugTargetsIndication121923_text_201285
DrugTargetsIndication121923_text_200750
DrugTargetsIndication121923_text_201075
DrugTargetsIndication121923_text_200745
DrugTargetsIndication121923_text_200800
DrugTargetsIndication121923_text_200980
DrugTargetsIndication121923_text_201175
DrugTargetsIndication121923_text_200970
DrugTargetsIndication121923_text_201005
DrugTargetsIndication121923_text_201035
DrugTargetsIndication121923_text_201155
DrugTargetsIndication121923_text_201205
DrugTargetsIndication121923_text_201110
DrugTargetsIndication121923_text_201270
DrugTargetsIndication121923_text_200935
DrugTargetsIndication121923_text_200865
DrugTargetsIndication121923_text_201160
DrugTargetsIndication121923_text_201000
DrugTargetsIndication121923_text_201170
DrugTargetsIndication121923_text_201070
DrugTargetsIndication121923_text_201085
DrugTargetsIndication121923_text_201115
DrugTargetsIndication121923_text_201140
DrugTargetsIndication121923_text_201080
DrugTargetsIndication121923_text_200740
DrugTargetsIndication121923_text_200790
DrugTargetsIndication121923_text_200955
DrugTargetsIndication121923_text_201125
DrugTargetsIndication121923_text_200900
DrugTargetsIndication121923_text_200815
DrugTargetsIndication121923_text_200930
DrugTargetsIndication121923_text_200730
DrugTargetsIndication121923_text_200760
DrugTargetsIndication121923_text_201030
DrugTargetsIndication121923_text_201050
DrugTargetsIndication121923_text_200860
DrugTargetsIndication121923_text_200915
DrugTargetsIndication121923_text_201180
DrugTargetsIndication121923_text_201195
DrugTargetsIndication121923_text_201330
DrugTargetsIndication121923_text_200770
DrugTargetsIndication121923_text_200780
DrugTargetsIndication121923_text_200985
DrugTargetsIndication121923_text_201165
DrugTargetsIndication121923_text_201020
DrugTargetsIndication121923_text_201065
DrugTargetsIndication121923_text_201190
DrugTargetsIndication121923_text_200765
DrugTargetsIndication121923_text_201200
DrugTargetsIndication121923_text_200975
DrugTargetsIndication121923_text_201145
DrugTargetsIndication121923_text_201235
DrugTargetsIndication121923_text_201295
DrugTargetsIndication121923_text_200755
DrugTargetsIndication121923_text_201095
DrugTargetsIndication121923_text_200885
DrugTargetsIndication121923_text_200890
DrugTargetsIndication121923_text_201245
DrugTargetsIndication121923_text_200905
DrugTargetsIndication121923_text_201280
DrugTargetsIndication121923_text_201320
DrugTargetsIndication121923_text_200880
DrugTargetsIndication121923_text_200855
DrugTargetsIndication121923_text_200945
DrugTargetsIndication121923_text_200960
DrugTargetsIndication121923_text_200950
DrugTargetsIndication121923_text_201015
DrugTargetsIndication121923_text_201130
DrugTargetsIndication121923_text_200775
DrugTargetsIndication121923_text_201315
DrugTargetsIndication121923_text_200715
DrugTargetsIndication121923_text_200795
DrugTargetsIndication121923_text_201060
DrugTargetsIndication121923_text_201290
DrugTargetsIndication121923_text_200735
DrugTargetsIndication121923_text_201185
DrugTargetsIndication121923_text_201300
DrugTargetsIndication121923_text_200825
DrugTargetsIndication121923_text_200830
DrugTargetsIndication121923_text_200965
DrugTargetsIndication121923_text_201010
DrugTargetsIndication121923_text_201025
DrugTargetsIndication121923_text_201150
DrugTargetsIndication121923_text_201265
DrugTargetsIndication121923_text_201310
DrugTargetsIndication121923_text_201325
DrugTargetsIndication121923_text_200895
DrugTargetsIndication121923_text_201225
DrugTargetsIndication121923_text_201045
DrugTargetsIndication121923_text_201090
DrugTargetsIndication121923_text_201230
DrugTargetsIndication121923_text_201260
DrugTargetsIndication121923_text_201040
DrugTargetsIndication121923_text_200940
DrugTargetsIndication121923_text_200995
DrugTargetsIndication121923_text_201240",7/22/2024,Maya,,Drug Disease relations; Drug Gene relations,,,What genes does x target when it's used to treat y?,,,,,
Q7,What are the approved uses for Rotigotine?,Rotigotine has been approved to treat Parkinson Disease and Restless Legs Syndrome. ,"DrugTargetsIndication121923_text_200751
DrugTargetsIndication121923_text_200846
DrugTargetsIndication121923_text_200941
DrugTargetsIndication121923_text_200976
DrugTargetsIndication121923_text_201012
DrugTargetsIndication121923_text_201071
DrugTargetsIndication121923_text_201182
DrugTargetsIndication121923_text_201262
DrugTargetsIndication121923_text_201322
DrugTargetsIndication121923_text_200822
DrugTargetsIndication121923_text_200876
DrugTargetsIndication121923_text_200892
DrugTargetsIndication121923_text_201006
DrugTargetsIndication121923_text_201117
DrugTargetsIndication121923_text_201167
DrugTargetsIndication121923_text_201001
DrugTargetsIndication121923_text_201062
DrugTargetsIndication121923_text_201122
DrugTargetsIndication121923_text_201276
DrugTargetsIndication121923_text_201326
DrugTargetsIndication121923_text_200817
DrugTargetsIndication121923_text_200907
DrugTargetsIndication121923_text_201042
DrugTargetsIndication121923_text_201172
DrugTargetsIndication121923_text_201211
DrugTargetsIndication121923_text_201301
DrugTargetsIndication121923_text_201327
DrugTargetsIndication121923_text_200961
DrugTargetsIndication121923_text_201027
DrugTargetsIndication121923_text_201061
DrugTargetsIndication121923_text_201212
DrugTargetsIndication121923_text_201246
DrugTargetsIndication121923_text_201256
DrugTargetsIndication121923_text_201267
DrugTargetsIndication121923_text_201332
DrugTargetsIndication121923_text_200726
DrugTargetsIndication121923_text_200826
DrugTargetsIndication121923_text_200827
DrugTargetsIndication121923_text_200867
DrugTargetsIndication121923_text_200922
DrugTargetsIndication121923_text_200946
DrugTargetsIndication121923_text_200986
DrugTargetsIndication121923_text_200987
DrugTargetsIndication121923_text_200992
DrugTargetsIndication121923_text_201101
DrugTargetsIndication121923_text_200757
DrugTargetsIndication121923_text_200956
DrugTargetsIndication121923_text_201136
DrugTargetsIndication121923_text_201331
DrugTargetsIndication121923_text_200916
DrugTargetsIndication121923_text_201076
DrugTargetsIndication121923_text_200902
DrugTargetsIndication121923_text_200971
DrugTargetsIndication121923_text_201011
DrugTargetsIndication121923_text_201077
DrugTargetsIndication121923_text_201191
DrugTargetsIndication121923_text_201192
DrugTargetsIndication121923_text_201197
DrugTargetsIndication121923_text_201307
DrugTargetsIndication121923_text_200742
DrugTargetsIndication121923_text_200837
DrugTargetsIndication121923_text_200882
DrugTargetsIndication121923_text_200932
DrugTargetsIndication121923_text_200712
DrugTargetsIndication121923_text_200771
DrugTargetsIndication121923_text_201052
DrugTargetsIndication121923_text_201111
DrugTargetsIndication121923_text_201271
DrugTargetsIndication121923_text_200816
DrugTargetsIndication121923_text_200852
DrugTargetsIndication121923_text_200936
DrugTargetsIndication121923_text_201296
DrugTargetsIndication121923_text_200807
DrugTargetsIndication121923_text_200861
DrugTargetsIndication121923_text_200951
DrugTargetsIndication121923_text_201137
DrugTargetsIndication121923_text_201232
DrugTargetsIndication121923_text_200906
DrugTargetsIndication121923_text_200996
DrugTargetsIndication121923_text_201017
DrugTargetsIndication121923_text_201142
DrugTargetsIndication121923_text_201151
DrugTargetsIndication121923_text_201171
DrugTargetsIndication121923_text_200766
DrugTargetsIndication121923_text_200811
DrugTargetsIndication121923_text_200912
DrugTargetsIndication121923_text_201187
DrugTargetsIndication121923_text_201226
DrugTargetsIndication121923_text_200787
DrugTargetsIndication121923_text_200791
DrugTargetsIndication121923_text_200981
DrugTargetsIndication121923_text_201156
DrugTargetsIndication121923_text_201247
DrugTargetsIndication121923_text_201266
DrugTargetsIndication121923_text_201277
DrugTargetsIndication121923_text_200871
DrugTargetsIndication121923_text_201121
DrugTargetsIndication121923_text_201181
DrugTargetsIndication121923_text_201217
DrugTargetsIndication121923_text_201306
DrugTargetsIndication121923_text_200842
DrugTargetsIndication121923_text_200851
DrugTargetsIndication121923_text_200957
DrugTargetsIndication121923_text_200991
DrugTargetsIndication121923_text_201066
DrugTargetsIndication121923_text_201157
DrugTargetsIndication121923_text_201207
DrugTargetsIndication121923_text_200722
DrugTargetsIndication121923_text_200952
DrugTargetsIndication121923_text_200977
DrugTargetsIndication121923_text_201152
DrugTargetsIndication121923_text_201176
DrugTargetsIndication121923_text_201291
DrugTargetsIndication121923_text_201292
DrugTargetsIndication121923_text_200746
DrugTargetsIndication121923_text_200862
DrugTargetsIndication121923_text_200891
DrugTargetsIndication121923_text_201051
DrugTargetsIndication121923_text_201126
DrugTargetsIndication121923_text_200792
DrugTargetsIndication121923_text_201082
DrugTargetsIndication121923_text_201201
DrugTargetsIndication121923_text_201216
DrugTargetsIndication121923_text_200772
DrugTargetsIndication121923_text_201007
DrugTargetsIndication121923_text_201047
DrugTargetsIndication121923_text_201067
DrugTargetsIndication121923_text_201096
DrugTargetsIndication121923_text_201106
DrugTargetsIndication121923_text_201131
DrugTargetsIndication121923_text_201161
DrugTargetsIndication121923_text_201086
DrugTargetsIndication121923_text_201227
DrugTargetsIndication121923_text_201286
DrugTargetsIndication121923_text_200777
DrugTargetsIndication121923_text_200927
DrugTargetsIndication121923_text_200801
DrugTargetsIndication121923_text_200806
DrugTargetsIndication121923_text_200836
DrugTargetsIndication121923_text_200931
DrugTargetsIndication121923_text_200782
DrugTargetsIndication121923_text_200942
DrugTargetsIndication121923_text_201166
DrugTargetsIndication121923_text_200901
DrugTargetsIndication121923_text_200967
DrugTargetsIndication121923_text_201021
DrugTargetsIndication121923_text_201162
DrugTargetsIndication121923_text_200711
DrugTargetsIndication121923_text_200721
DrugTargetsIndication121923_text_200736
DrugTargetsIndication121923_text_201321
DrugTargetsIndication121923_text_200747
DrugTargetsIndication121923_text_200781
DrugTargetsIndication121923_text_200856
DrugTargetsIndication121923_text_200897
DrugTargetsIndication121923_text_200972
DrugTargetsIndication121923_text_201026
DrugTargetsIndication121923_text_201072
DrugTargetsIndication121923_text_201177
DrugTargetsIndication121923_text_201231
DrugTargetsIndication121923_text_200717
DrugTargetsIndication121923_text_200796
DrugTargetsIndication121923_text_200812
DrugTargetsIndication121923_text_201036
DrugTargetsIndication121923_text_201206
DrugTargetsIndication121923_text_201222
DrugTargetsIndication121923_text_201261
DrugTargetsIndication121923_text_200761
DrugTargetsIndication121923_text_200776
DrugTargetsIndication121923_text_200786
DrugTargetsIndication121923_text_200797
DrugTargetsIndication121923_text_200887
DrugTargetsIndication121923_text_201002
DrugTargetsIndication121923_text_201016
DrugTargetsIndication121923_text_201046
DrugTargetsIndication121923_text_201087
DrugTargetsIndication121923_text_200731
DrugTargetsIndication121923_text_200737
DrugTargetsIndication121923_text_200917
DrugTargetsIndication121923_text_200997
DrugTargetsIndication121923_text_201107
DrugTargetsIndication121923_text_201112
DrugTargetsIndication121923_text_201221
DrugTargetsIndication121923_text_200716
DrugTargetsIndication121923_text_200732
DrugTargetsIndication121923_text_200741
DrugTargetsIndication121923_text_200752
DrugTargetsIndication121923_text_200962
DrugTargetsIndication121923_text_201141
DrugTargetsIndication121923_text_201147
DrugTargetsIndication121923_text_201241
DrugTargetsIndication121923_text_201242
DrugTargetsIndication121923_text_200847
DrugTargetsIndication121923_text_200881
DrugTargetsIndication121923_text_201056
DrugTargetsIndication121923_text_201146
DrugTargetsIndication121923_text_200857
DrugTargetsIndication121923_text_201031
DrugTargetsIndication121923_text_201081
DrugTargetsIndication121923_text_200886
DrugTargetsIndication121923_text_200911
DrugTargetsIndication121923_text_201302
DrugTargetsIndication121923_text_200802
DrugTargetsIndication121923_text_200877
DrugTargetsIndication121923_text_201316
DrugTargetsIndication121923_text_201317
DrugTargetsIndication121923_text_200921
DrugTargetsIndication121923_text_201032
DrugTargetsIndication121923_text_201037
DrugTargetsIndication121923_text_201041
DrugTargetsIndication121923_text_201097
DrugTargetsIndication121923_text_200926
DrugTargetsIndication121923_text_200982
DrugTargetsIndication121923_text_201252
DrugTargetsIndication121923_text_201336
DrugTargetsIndication121923_text_200896
DrugTargetsIndication121923_text_201116
DrugTargetsIndication121923_text_201251
DrugTargetsIndication121923_text_201312
DrugTargetsIndication121923_text_200821
DrugTargetsIndication121923_text_200937
DrugTargetsIndication121923_text_201186
DrugTargetsIndication121923_text_201196
DrugTargetsIndication121923_text_201311
DrugTargetsIndication121923_text_201337
DrugTargetsIndication121923_text_200756
DrugTargetsIndication121923_text_200832
DrugTargetsIndication121923_text_200872
DrugTargetsIndication121923_text_201057
DrugTargetsIndication121923_text_201237
DrugTargetsIndication121923_text_201257
DrugTargetsIndication121923_text_201297
DrugTargetsIndication121923_text_200831
DrugTargetsIndication121923_text_200866
DrugTargetsIndication121923_text_201092
DrugTargetsIndication121923_text_201127
DrugTargetsIndication121923_text_201132
DrugTargetsIndication121923_text_201202
DrugTargetsIndication121923_text_201281
DrugTargetsIndication121923_text_201287
DrugTargetsIndication121923_text_200767
DrugTargetsIndication121923_text_200841
DrugTargetsIndication121923_text_200947
DrugTargetsIndication121923_text_201022
DrugTargetsIndication121923_text_201091
DrugTargetsIndication121923_text_201102
DrugTargetsIndication121923_text_201236
DrugTargetsIndication121923_text_200727
DrugTargetsIndication121923_text_200966
DrugTargetsIndication121923_text_200762
DrugTargetsIndication121923_text_201272
DrugTargetsIndication121923_text_201282",7/22/2024,Maya,,Drug meta,,,What are the approved uses for x?,x has been approved by the FDA to treat [comma sep list with and]. ,The drug x has not been approved by the FDA for treatment of any disease but has reached phase y clinical trials.,,,
Q8,Is Rg-7841 approved by the FDA for any disease treatment?,The drug Rg-7841 is not approved by the FDA for treatment of any disease but has reached phase 1 clinical trials.,DrugGeneTargets_v1_831                                                         DrugGeneTargets_v1_832,7/22/2024,Maya ,,Drug meta,,,Is x approved by the FDA for any disease treatment?,,,,,
Q9,Is Vinblastine Sulfate approved by the FDA and if so when was it?,"Yes, the drug Vinblastine Sulfate was first FDA approved for use in 1965.",DrugGeneTargets_v1_6261,7/22/2024,Maya,,Drug meta,,,Is x approved by the FDA and if so when was it?,,,,,
Q10,Are there any CR1 SNPs that have a statistically significant association with Alzheimer's Disease?,"Yes, the CR1 gene has 47 SNPs that were found to be significantly associated with an increased risk of Alzheimer's disease. Here are the top SNPs according to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022):
• rs6656401 (GWAS P-value: 2.84E-33; b value: 0.1253)
• rs679515 (GWAS P-value: 5.15E-33; b value: 0.1244)
• rs4562624 (GWAS P-value: 1.11E-32; b value: 0.124)
• rs4844610 (GWAS P-value: 11.14E-32; b value: 0.1238)
• rs12037841 (GWAS P-value: 2.69E-32; b value: 0.1234)
• rs1408077 (GWAS P-value: 2.72E-31; b value: 0.1198)
• rs10863417 (GWAS P-value: 3.19E-31; b value: 0.1199)
• rs10863418 (GWAS P-value: 3.31E-31; b value: 0.1189)
• rs1752684 (GWAS P-value: 4.01E-31; b value: 0.1195)
• rs10863420 (GWAS P-value: 4.33E-31; b value: 0.1195)
","AD_combo_gene_notext_UUID_1352743
AD_combo_gene_notext_UUID_1352901
AD_combo_gene_notext_UUID_1352711
AD_combo_gene_notext_UUID_1353285
AD_combo_gene_notext_UUID_1352701
AD_combo_gene_notext_UUID_1353301
AD_combo_gene_notext_UUID_1353247
AD_combo_gene_notext_UUID_1353256
AD_combo_gene_notext_UUID_1352868
AD_combo_gene_notext_UUID_1353273
AD_combo_gene_notext_UUID_1353277
AD_combo_gene_notext_UUID_1353316
AD_combo_gene_notext_UUID_1353262
AD_combo_gene_notext_UUID_1353279
AD_combo_gene_notext_UUID_1353235
AD_combo_gene_notext_UUID_1353168
AD_combo_gene_notext_UUID_1353161
AD_combo_gene_notext_UUID_1353151
AD_combo_gene_notext_UUID_1353172
AD_combo_gene_notext_UUID_1353261
AD_combo_gene_notext_UUID_1352788
AD_combo_gene_notext_UUID_1352709
AD_combo_gene_notext_UUID_1352659
AD_combo_gene_notext_UUID_1353238
AD_combo_gene_notext_UUID_1353221
AD_combo_gene_notext_UUID_1353189
AD_combo_gene_notext_UUID_1353264
AD_combo_gene_notext_UUID_1353294
AD_combo_gene_notext_UUID_1353308
AD_combo_gene_notext_UUID_1353288
AD_combo_gene_notext_UUID_1353278
AD_combo_gene_notext_UUID_1353291
AD_combo_gene_notext_UUID_1353246
AD_combo_gene_notext_UUID_1353317
AD_combo_gene_notext_UUID_1352918
AD_combo_gene_notext_UUID_1353160
AD_combo_gene_notext_UUID_1353158
AD_combo_gene_notext_UUID_1352838
AD_combo_gene_notext_UUID_1352930
AD_combo_gene_notext_UUID_1352639
AD_combo_gene_notext_UUID_1352825
AD_combo_gene_notext_UUID_1352638
AD_combo_gene_notext_UUID_1352803
AD_combo_gene_notext_UUID_1352823
AD_combo_gene_notext_UUID_1352621
AD_combo_gene_notext_UUID_1352601
AD_combo_gene_notext_UUID_1352600",8/21/2024,Maya/Mary,,Snp disease relations; Gene disease relations ,,,Are there any x SNPs that have a statistically significant association with y?,Yes there are (count significant) SNPs that's have a significant association with y. Here are the top 5:  snp tissue pvalue effect size ,"No, based on the (list tissue samples comma separated with second to last one separated by , and ) samples tested there are no alleles within the gene x that are significantly associated with Y.",,,
Q11,Are there any CR1 SNPs that have a statistically significant adjusted SMR p-value in association with Alzheimer's Disease and what tissues are they significant in?,"Yes, the CR1 gene has 4 SNPs that are statistically significant in Alzheimer's Disease in tissues. Here are the SNPs along with their adjusted SMR p-values:
• rs679515
    • Prefrontal cortex: Adjusted SMR multi-SNP P-value: 1.08E-12; HEIDI: 0.0028
    • Whole brain: Adjusted SMR multi-SNP P-value: 2.10E-12; HEIDI: 0.2568
    • Multi ancestry whole brain: Adjusted SMR multi-SNP P-value: 2.09E-15; HEIDI: 9.09e-08
    • Cortex: Adjusted SMR multi-SNP P-value: 4.46E-08; HEIDI: 0.9563

• rs1830763
    • Cortex: Adjusted SMR multi-SNP P-value: 3.83E-15; HEIDI: 0.0603
    • Cerebellum: Adjusted SMR multi-SNP P-value: 1.72E-08; HEIDI: 0.1092

• rs2093760
    • Caudate basal ganglia: Adjusted SMR multi-SNP P-value: 3.25E-08; HEIDI: 0.5329

• rs6697005
    • Basal ganglia: Adjusted SMR multi-SNP P-value: 2.48E-08; HEIDI: 0.0786","NDD_SMR_genes_all_update_text_2441
NDD_SMR_genes_all_update_text_1105231
NDD_SMR_genes_all_update_text_1265685
NDD_SMR_genes_all_update_text_24520
NDD_SMR_genes_all_update_text_1195476
NDD_SMR_genes_all_update_text_1605472
NDD_SMR_genes_all_update_text_1389608
NDD_SMR_genes_all_update_text_1244290",8/21/2024,Maya/Mary,,SMR Snp disease relations; SMR Gene disease relations ,,,Are there any x SNPs that have a statistically significant association with y?,Yes there are (count significant) SNPs that's have a significant association with y. Here are the top 5:  snp tissue pvalue effect size ,"No, based on the (list tissue samples comma separated with second to last one separated by , and ) samples tested there are no alleles within the gene x that are significantly associated with Y.",,,
Q12,what other names are there for the drug Vinblastine Sulfate?,"Some additional names for Vinblastine Sulfate are 29060-LE, 29060LE, Alkaban-aq, NSC-49842, Vinblastine sulfate, Vinblastine sulphate, Vinblastini sulfas, Vincaleukoblastine sulfate, Vlb monosulfate, Velban, Velbe, and Vinblast,lederle.",DrugGeneTargets_v1_6261,7/22/2024,Maya,,Drug meta,,,what other names are there for the drug x?,,,,,
Q13,Is ANGPTL8 significantly associated with any neurological diseases?,"No, based on the research conducted on the following neurological diseases, the gene ANGPTL8 is not found to be significantly associated with:
Alzheimer's Disease (AD)
Frontotemporal Dementia (FTD)
Lewy Body Dementia (LBD)
Parkinson's Disease (PD)
Amyotrophic Lateral Sclerosis (ALS)
Progressive Supranuclear Palsy (PSP)","NDD_SMR_genes_all_update_text_1107751
NDD_SMR_genes_all_update_text_1151716
NDD_SMR_genes_all_update_text_1114471
NDD_SMR_genes_all_update_text_1126904
NDD_SMR_genes_all_update_text_1139723
NDD_SMR_genes_all_update_text_1138430",7/22/2024,Maya/Marzieh,,Gene disease relations ,,,Is x significantly associated with any neurological diseases?,,,,,
Q14,What mechanism type does the drug Testosterone Enanthate use? ,The drug Testosterone Enanthate is an agonist. ,DrugGeneTargets_v1_5959,7/22/2024,Maya,,Pharmacology ,,,What mechanism type does the drug x use? ,,,,,
Q15,When was Escitalopram approved by the FDA?,The drug Escitalopram was first FDA approved for use in 2002.,DrugGeneTargets_v1_767,7/22/2024,Maya,,Drug meta,,,,,,,,
Q16,What cell therapies have been approved by the FDA to treat prostate cancer? ,Sipuleucel-T is the only cell therapy approved to treat prostate cancer.,DrugGeneTargets_v1_2303,8/9/2024,Maya,,Pharmacology; Drug Disease relations; Drug meta,,,,,,,,
Q17,What gene does the drug Ocaliva target?,Ocaliva targets the gene NR1H4.,DrugGeneTargets_v2_3863,8/27/2024,Maya/Mary,,Drug Gene relations,,,What gene does the drug x target?,,,,,
Q18,For which condition is Sonidegib Phosphate indicated according to the Experimental Factor Ontology (EFO) and Medical Subject Headings (MeSH)?,"Sonidegib Phosphate is indicated for the treatment of basal cell carcinoma, according to EFO (EFO:0004193) and MeSH (Carcinoma, Basal Cell, D002280).","DrugTargetsIndication121923_text_1072620 
DrugTargetsIndication121923_text_1072622 
DrugTargetsIndication121923_text_1072621",July 3th,Marzieh,,Drug Disease relations,,,,,,,,
Q19,What SNP is most significantly associated with AD in Caudate Basal Ganglia?,"The most significantly associated SNP with Alzheimer's Disease in the Caudate Basal Ganglia is rs2288911, located in the APOC2 gene, with a multi SMR p value of 1.951e-10
and a p HEIDI value of 2.226e-07.",NDD_SMR_genes_all_update_text_1268425,07/29/2024,Maya,,Tissue; SMR Snp disease relations ,,,What SNP is most significantly associated with AD in x?,,,,,
Q20,How do the SMR associations between rs10256524 and Alzheimer's disease or Parkinson's disease risk differ across different brain tissues?,"Here are the associations between rs10256524 and Alzheimer's disease or Parkinson's in different brain tissues:
Parkinson's Disease:
• In the Amygdala, rs10256524 exhibits a functionally significant association (Adjusted SMR multi-SNP P-value: 2.34e-06, HEIDI: 0.018).
• Similarly, in the Frontal Cortex BA9, rs10256524 shows a functionally significant association (Adjusted SMR multi-SNP P-value: 4.74e-07, HEIDI: 0.013).
Alzheimer's Disease:
• In both the Amygdala and the Frontal Cortex BA9, rs10256524 does not show a functionally significant association.","NDD_SMR_genes_all_update_text_1167541
NDD_SMR_genes_all_update_text_1155910
NDD_SMR_genes_all_update_text_1603159
NDD_SMR_genes_all_update_text_1597657
",08/21/2024,Maya,,Tissue; SMR Snp disease relations ,,,,,,,,
Q21,"How many synonym names does Sonidegib Phosphate have, and what are they?","Sonidegib Phosphate has 3 synonym names: Erismodegib phosphate, Sonidegib diphosphate, and Sonidegib phosphate.","DrugTargetsIndication121923_text_1072620 
DrugTargetsIndication121923_text_1072622 
DrugTargetsIndication121923_text_1072621",July 3th,Marzieh,,Drug meta,,,,,,,,
Q22,What is Aplenzin?,"Aplenzin, also known generically as bupropion hydrobromide, is used to treat major depressive disorder. It is a small molecule drug that acts as an inhibitor. ","DrugTargetsIndication121923_text_434167
DrugTargetsIndication121923_text_434188
DrugTargetsIndication121923_text_434177
DrugTargetsIndication121923_text_434149
DrugTargetsIndication121923_text_434153
DrugTargetsIndication121923_text_434189
DrugTargetsIndication121923_text_434224
DrugTargetsIndication121923_text_434229
DrugTargetsIndication121923_text_434203
DrugTargetsIndication121923_text_434168
DrugTargetsIndication121923_text_434205
DrugTargetsIndication121923_text_434183
DrugTargetsIndication121923_text_434238
DrugTargetsIndication121923_text_434200
DrugTargetsIndication121923_text_434162
DrugTargetsIndication121923_text_434191
DrugTargetsIndication121923_text_434212
DrugTargetsIndication121923_text_434223
DrugTargetsIndication121923_text_434222
DrugTargetsIndication121923_text_434166
DrugTargetsIndication121923_text_434192
DrugTargetsIndication121923_text_434213
DrugTargetsIndication121923_text_434146
DrugTargetsIndication121923_text_434232
DrugTargetsIndication121923_text_434171
DrugTargetsIndication121923_text_434227
DrugTargetsIndication121923_text_434173
DrugTargetsIndication121923_text_434176
DrugTargetsIndication121923_text_434204
DrugTargetsIndication121923_text_434147
DrugTargetsIndication121923_text_434230
DrugTargetsIndication121923_text_434161
DrugTargetsIndication121923_text_434198
DrugTargetsIndication121923_text_434226
DrugTargetsIndication121923_text_434233
DrugTargetsIndication121923_text_434156
DrugTargetsIndication121923_text_434196
DrugTargetsIndication121923_text_434197
DrugTargetsIndication121923_text_434195
DrugTargetsIndication121923_text_434219
DrugTargetsIndication121923_text_434178
DrugTargetsIndication121923_text_434182
DrugTargetsIndication121923_text_434193
DrugTargetsIndication121923_text_434235
DrugTargetsIndication121923_text_434155
DrugTargetsIndication121923_text_434165
DrugTargetsIndication121923_text_434151
DrugTargetsIndication121923_text_434152
DrugTargetsIndication121923_text_434225
DrugTargetsIndication121923_text_434159
DrugTargetsIndication121923_text_434187
DrugTargetsIndication121923_text_434234
DrugTargetsIndication121923_text_434239
DrugTargetsIndication121923_text_434172
DrugTargetsIndication121923_text_434174
DrugTargetsIndication121923_text_434181
DrugTargetsIndication121923_text_434208
DrugTargetsIndication121923_text_434214
DrugTargetsIndication121923_text_434216
DrugTargetsIndication121923_text_434194
DrugTargetsIndication121923_text_434228
DrugTargetsIndication121923_text_434199
DrugTargetsIndication121923_text_434221
DrugTargetsIndication121923_text_434157
DrugTargetsIndication121923_text_434215
DrugTargetsIndication121923_text_434218
DrugTargetsIndication121923_text_434164
DrugTargetsIndication121923_text_434180
DrugTargetsIndication121923_text_434184
DrugTargetsIndication121923_text_434145
DrugTargetsIndication121923_text_434158
DrugTargetsIndication121923_text_434160
DrugTargetsIndication121923_text_434150
DrugTargetsIndication121923_text_434185
DrugTargetsIndication121923_text_434163
DrugTargetsIndication121923_text_434210
DrugTargetsIndication121923_text_434220
DrugTargetsIndication121923_text_434236
DrugTargetsIndication121923_text_434148
DrugTargetsIndication121923_text_434169
DrugTargetsIndication121923_text_434217
DrugTargetsIndication121923_text_434237
DrugTargetsIndication121923_text_434201
DrugTargetsIndication121923_text_434170
DrugTargetsIndication121923_text_434202
DrugTargetsIndication121923_text_434144
DrugTargetsIndication121923_text_434175
DrugTargetsIndication121923_text_434231
DrugTargetsIndication121923_text_434179
DrugTargetsIndication121923_text_434206
DrugTargetsIndication121923_text_434207
DrugTargetsIndication121923_text_434211
DrugTargetsIndication121923_text_434190
DrugTargetsIndication121923_text_434186
DrugTargetsIndication121923_text_434209
DrugTargetsIndication121923_text_434154",08/27/2024,Mary/Maya,,Drug meta; Pharmacology,,,,,,,,
Q23,Is there a black box warning for the drug Brentuximab Vedotin? ,"Yes, the drug Brentuximab Vedotin has a black box warning from the FDA.","DrugGeneTargets_v1_1084
DrugGeneTargets_v1_1085",08/09/2024,Maya,,Drug meta,,,,,,,,
Q24,Are there any oligonucleotide therapies that are in phase 2 clinical trials?,"Yes, there are 16 oligonucleotide therapies that have a maximum clinical trial phase of 2:
Imetelstat Sodium, Vupanorsen, Bamosiran, Olpasiran, Suvodirsen, Sepofarsen, Aganirsen, Cenersen Sodium, Volanesorsen Sodium, Sapablursen, Prexigebersen, Cenersen, Cofirasersen, Gataparsen, Apatorsen, Danvatirsen. ",DrugGeneTargets_v1_403                                                                                                                                                                                                                                                                                               DrugGeneTargets_v1_2325                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_2326                                                                                                                                                                                                                                                                                             DrugGeneTargets_v1_453                                                                                                                                                                                                                                                                                            DrugGeneTargets_v1_3555                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_1833                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_1360                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_4843                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_444                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_3223                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5289                                                                                                                                                                                                                                                                                            DrugGeneTargets_v1_6066                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_2734                                                                                                                                                                                                                                                                                                                                    DrugGeneTargets_v1_1778                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_3583                                                                                                                                                                                                                                                                                           DrugGeneTargets_v1_1706                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_4959,08/06/2024,Mary/Maya,,Drug meta; Pharmacology,,,,,,,,
Q25,What is the effect size of rs112485576 in Parkinson's disease?,"The effect size, or beta, of rs112485576 is -0.1871 according to the largest European genome-wide meta-analysis of Parkinson's disease (Nalls et al., 2019).",PDno23andme_full_gene_notext_1635378,07/22/2024,Mary/Maya,,Snp disease relations ,,,What is the effect size of x in Parkinson's disease?,,,,,
Q26,How many SNPs are genome-wide significant in chr10 for Parkinson's disease?,"There are 4 SNPs that are genome-wide significant (p-value < 5E-8) within chr10 in the largest European genome-wide meta-analysis of Parkinson's disease (Nalls et al., 2019):
• rs118117788 (GWAS P-value: 1.33E-09)
• rs144814361 (GWAS P-value: 9.07E-11)
• rs117896735 (GWAS P-value: 2.83E-10)
• rs188789342 (GWAS P-value: 8.49E-10)","PDno23andme_full_gene_notext_1145950
PDno23andme_full_gene_notext_4158122
PDno23andme_full_gene_notext_933245
PDno23andme_full_gene_notext_4171570",07/22/2024,Mary/Marzieh,,Snp disease relations; Genomic location ,,,,,,,,
Q27,When was Donepezil approved to treat Alzheimer's disease?,The drug Donepezil was approved to treat Alzheimer's disease in 1996. ,"DrugTargetsIndication121923_text_993824
DrugTargetsIndication121923_text_993944
DrugTargetsIndication121923_text_993884
DrugTargetsIndication121923_text_993800
DrugTargetsIndication121923_text_993896
DrugTargetsIndication121923_text_993788
DrugTargetsIndication121923_text_993920
DrugTargetsIndication121923_text_993836
DrugTargetsIndication121923_text_993860
DrugTargetsIndication121923_text_993908
DrugTargetsIndication121923_text_993848
DrugTargetsIndication121923_text_993812
DrugTargetsIndication121923_text_993872
DrugTargetsIndication121923_text_993956
DrugTargetsIndication121923_text_993932",7/22/2024,Maya,,Drug Disease relations; Drug meta,,,,,,,,
Q28,What drugs are approved to treat AD? ,"There are two drugs that are approved to treat Alzheimer's disease:
• Donepezil Hydrochloride, which was approved in 1996
•Memantine Hydrochloride, which was approved in 2003
","DrugTargetsIndication121923_text_993836
DrugTargetsIndication121923_text_455022
DrugTargetsIndication121923_text_455428
DrugTargetsIndication121923_text_454994
DrugTargetsIndication121923_text_455554
DrugTargetsIndication121923_text_455708
DrugTargetsIndication121923_text_993824
DrugTargetsIndication121923_text_993944
DrugTargetsIndication121923_text_455246
DrugTargetsIndication121923_text_455568
DrugTargetsIndication121923_text_455288
DrugTargetsIndication121923_text_455316
DrugTargetsIndication121923_text_455064
DrugTargetsIndication121923_text_455106
DrugTargetsIndication121923_text_993848
DrugTargetsIndication121923_text_993884
DrugTargetsIndication121923_text_455190
DrugTargetsIndication121923_text_455386
DrugTargetsIndication121923_text_455218
DrugTargetsIndication121923_text_455302
DrugTargetsIndication121923_text_455652
DrugTargetsIndication121923_text_455274
DrugTargetsIndication121923_text_455512
DrugTargetsIndication121923_text_455596
DrugTargetsIndication121923_text_455134
DrugTargetsIndication121923_text_455414
DrugTargetsIndication121923_text_455120
DrugTargetsIndication121923_text_455722
DrugTargetsIndication121923_text_455638
DrugTargetsIndication121923_text_455260
DrugTargetsIndication121923_text_455400
DrugTargetsIndication121923_text_455092
DrugTargetsIndication121923_text_455456
DrugTargetsIndication121923_text_993860
DrugTargetsIndication121923_text_455050
DrugTargetsIndication121923_text_455750
DrugTargetsIndication121923_text_455484
DrugTargetsIndication121923_text_455736
DrugTargetsIndication121923_text_993920
DrugTargetsIndication121923_text_455344
DrugTargetsIndication121923_text_455610
DrugTargetsIndication121923_text_455442
DrugTargetsIndication121923_text_993956
DrugTargetsIndication121923_text_455204
DrugTargetsIndication121923_text_455498
DrugTargetsIndication121923_text_993908
DrugTargetsIndication121923_text_455162
DrugTargetsIndication121923_text_455470
DrugTargetsIndication121923_text_455540
DrugTargetsIndication121923_text_455148
DrugTargetsIndication121923_text_455372
DrugTargetsIndication121923_text_455036
DrugTargetsIndication121923_text_993788
DrugTargetsIndication121923_text_455680
DrugTargetsIndication121923_text_455330
DrugTargetsIndication121923_text_993800
DrugTargetsIndication121923_text_993896
DrugTargetsIndication121923_text_455666
DrugTargetsIndication121923_text_455078
DrugTargetsIndication121923_text_455694
DrugTargetsIndication121923_text_993872
DrugTargetsIndication121923_text_455176
DrugTargetsIndication121923_text_993812
DrugTargetsIndication121923_text_455232
DrugTargetsIndication121923_text_455358
DrugTargetsIndication121923_text_993932
DrugTargetsIndication121923_text_455008
DrugTargetsIndication121923_text_455526
DrugTargetsIndication121923_text_455582
DrugTargetsIndication121923_text_455624
DrugTargetsIndication121923_text_455764",7/22/2024,Maya,,Drug Disease relations; Drug meta,More but only listed two in table,,,,,,,
Q29,What SNP is most significantly associated with PSP in spinal cord tissue?,"The most significantly associated SNP with Progressive supranuclear palsy in Spinal Cord eQTL omic data is rs8070723, located in the LRRC37A2 gene, with a multi SNP SMR p value of 2.163e-11 and a HEIDI value of 1.775e-07.",NDD_SMR_genes_all_update_text_30484,7/22/2024,Maya,,Tissue; SMR Snp disease relations ,,,,,,,,
Q30,Is the gene GRIA4 targeted by multiple different approved drugs to treat PD?,"Yes, the gene GRIA4 is targeted by two drugs for the treatment of PD:
•Topiramate
•Perampanel",DrugGeneTargets_v1_1592                                                                           DrugGeneTargets_v1_2165,8/13/2024,Maya,,Drug Gene relations; Drug Disease relations; Drug meta,,,,,,,,
Q31,Has the FDA approved any drugs targeting the gene APOE for the treatment of neurodegenerative diseases?,"No, as of now, the FDA hasn't approved any drugs targeting the gene APOE for the treatment of neurodegenerative diseases.",`card-ai-389220.card_ai_june_mvp.DrugTargetIndications`,7/22/2024,Maya,,Drug Gene relations; Drug Disease relations; Drug meta,,,,,,,,
Q32,What is the top SNP in blood for Lewy Body Dementia?,"The top SNP when analyzing whole blood in Lewy Body Dementia is rs17561351, located in the PVRL2 gene, with a multi SNP SMR p value of 2.638e-25 and a p Heidi of 2.172e-14",NDD_SMR_genes_all_update_text_1550598,7/22/2024,Mary/Maya,,Tissue; SMR Snp disease relations ,,,What is the top SNP in x for y?,,,,,
Q33,What is the allele frequency of the SNP rs2075650 in the context of Parkinson's disease?,"In the largest European genome-wide meta-analysis of Parkinson's disease from Nalls (2019), single nucleotide polymorphism rs2075650 has an alternate allele (G) frequency of 0.131 and reference
allele (A) frequency of 0.869.",PDno23andme_full_gene_notext_378423,7/22/2024,Maya,,Snp disease relations ,,,,,,,,
Q34,What are the names of the genes that are targeted by the drug Levodopa in the treatment of Parkinson's disease?,"In the context of Parkinson's disease, the drug Levodopa targets the gene dopamine receptor D3.","DrugTargetsIndication121923_text_205011
DrugTargetsIndication121923_text_205086
DrugTargetsIndication121923_text_204911
DrugTargetsIndication121923_text_204961
DrugTargetsIndication121923_text_204861
DrugTargetsIndication121923_text_205061
DrugTargetsIndication121923_text_205036
DrugTargetsIndication121923_text_204886
DrugTargetsIndication121923_text_204936
DrugTargetsIndication121923_text_204986",8/22/2024,Maya,,Drug Gene relations; Drug Disease relations,,,,,,,,
Q35,Is the SNP rs12032182 significant in AD? ,"No, according to the GWAS summary statistics for AD from Bellenguez (2022), the SNP rs12032182 has a p-value of 0.4058 and therefore is not significant in AD. ",AD_combo_gene_notext_UUID_32322,7/29/2024,Maya,,Snp disease relations ,,,,,,,,
Q36,What is the genomic location of SNP rs12032182 ,"The SNP rs12032182 is located on chromosome 1:
• Genomic Build GrCh37/HG19: base pair position 4431315
• Genomic Build GrCh38: base pair position 4371255","AD_combo_gene_notext_UUID_32322
PDno23andme_full_gene_notext_6154340",7/22/2024,Maya,,Genomic location,,,What is the genomic location of SNP x?,"The SNP x is located on chromosome y:
• Genomic Build GrCh37/HG19: base pair position z
• Genomic Build GrCh38: base pair position q",,,,
Q37,Which genes are targeted by the drug Dasatinib in the treatment of Alzheimer's disease?,"The drug Dasatinib has not been approved by the FDA as a treatment for Alzheimer's disease (AD), but it is currently undergoing evaluation in clinical trials for this purpose. However, there are 15 proposed gene targets: KIT, BCR, ABL1, PDGFRB, SRC, FRK, YES1, BLK, SRMS, LCK, LYN, FYN, EPHA2, FGR, and HCK.","DrugTargetsIndication121923_text_731956
DrugTargetsIndication121923_text_741628
DrugTargetsIndication121923_text_742408
DrugTargetsIndication121923_text_725638
DrugTargetsIndication121923_text_733594
DrugTargetsIndication121923_text_735388
DrugTargetsIndication121923_text_742720
DrugTargetsIndication121923_text_717760
DrugTargetsIndication121923_text_738040
DrugTargetsIndication121923_text_736714
DrugTargetsIndication121923_text_742486
DrugTargetsIndication121923_text_713704
DrugTargetsIndication121923_text_725170
DrugTargetsIndication121923_text_731020
DrugTargetsIndication121923_text_731254
DrugTargetsIndication121923_text_730162
DrugTargetsIndication121923_text_739288
DrugTargetsIndication121923_text_737338
DrugTargetsIndication121923_text_720880
DrugTargetsIndication121923_text_732112
DrugTargetsIndication121923_text_723688
DrugTargetsIndication121923_text_742018
DrugTargetsIndication121923_text_723610
DrugTargetsIndication121923_text_730552
DrugTargetsIndication121923_text_714406
DrugTargetsIndication121923_text_726340
DrugTargetsIndication121923_text_717604
DrugTargetsIndication121923_text_723922
DrugTargetsIndication121923_text_727978
DrugTargetsIndication121923_text_730396
DrugTargetsIndication121923_text_721582
DrugTargetsIndication121923_text_726106
DrugTargetsIndication121923_text_722752
DrugTargetsIndication121923_text_725326
DrugTargetsIndication121923_text_735076
DrugTargetsIndication121923_text_737104
DrugTargetsIndication121923_text_714796
DrugTargetsIndication121923_text_717682
DrugTargetsIndication121923_text_733360
DrugTargetsIndication121923_text_719398
DrugTargetsIndication121923_text_729226
DrugTargetsIndication121923_text_732580
DrugTargetsIndication121923_text_717214
DrugTargetsIndication121923_text_739210
DrugTargetsIndication121923_text_725014
DrugTargetsIndication121923_text_722128
DrugTargetsIndication121923_text_731488
DrugTargetsIndication121923_text_713158
DrugTargetsIndication121923_text_731566
DrugTargetsIndication121923_text_737026
DrugTargetsIndication121923_text_741472
DrugTargetsIndication121923_text_723064
DrugTargetsIndication121923_text_735934
DrugTargetsIndication121923_text_722284
DrugTargetsIndication121923_text_725950
DrugTargetsIndication121923_text_728758
DrugTargetsIndication121923_text_731722
DrugTargetsIndication121923_text_732424
DrugTargetsIndication121923_text_734842
DrugTargetsIndication121923_text_716122
DrugTargetsIndication121923_text_724546
DrugTargetsIndication121923_text_714484
DrugTargetsIndication121923_text_715186
DrugTargetsIndication121923_text_724000
DrugTargetsIndication121923_text_715810
DrugTargetsIndication121923_text_732034
DrugTargetsIndication121923_text_721972
DrugTargetsIndication121923_text_729304
DrugTargetsIndication121923_text_715264
DrugTargetsIndication121923_text_722596
DrugTargetsIndication121923_text_727354
DrugTargetsIndication121923_text_727120
DrugTargetsIndication121923_text_731878
DrugTargetsIndication121923_text_742330
DrugTargetsIndication121923_text_730240
DrugTargetsIndication121923_text_742798
DrugTargetsIndication121923_text_722908
DrugTargetsIndication121923_text_725092
DrugTargetsIndication121923_text_723454
DrugTargetsIndication121923_text_715654
DrugTargetsIndication121923_text_728992
DrugTargetsIndication121923_text_729148
DrugTargetsIndication121923_text_735544
DrugTargetsIndication121923_text_740770
DrugTargetsIndication121923_text_716980
DrugTargetsIndication121923_text_734140
DrugTargetsIndication121923_text_738508
DrugTargetsIndication121923_text_715420
DrugTargetsIndication121923_text_715576
DrugTargetsIndication121923_text_715732
DrugTargetsIndication121923_text_726418
DrugTargetsIndication121923_text_730318
DrugTargetsIndication121923_text_716044
DrugTargetsIndication121923_text_725560
DrugTargetsIndication121923_text_739600
DrugTargetsIndication121923_text_721660
DrugTargetsIndication121923_text_734452
DrugTargetsIndication121923_text_724390
DrugTargetsIndication121923_text_734920
DrugTargetsIndication121923_text_727276
DrugTargetsIndication121923_text_729850
DrugTargetsIndication121923_text_713314
DrugTargetsIndication121923_text_721114
DrugTargetsIndication121923_text_732502
DrugTargetsIndication121923_text_713548
DrugTargetsIndication121923_text_713626
DrugTargetsIndication121923_text_725872
DrugTargetsIndication121923_text_726262
DrugTargetsIndication121923_text_739444
DrugTargetsIndication121923_text_738742
DrugTargetsIndication121923_text_723844
DrugTargetsIndication121923_text_732814
DrugTargetsIndication121923_text_725248
DrugTargetsIndication121923_text_728290
DrugTargetsIndication121923_text_714172
DrugTargetsIndication121923_text_724858
DrugTargetsIndication121923_text_737494
DrugTargetsIndication121923_text_716434
DrugTargetsIndication121923_text_734062
DrugTargetsIndication121923_text_734998
DrugTargetsIndication121923_text_742174
DrugTargetsIndication121923_text_739834
DrugTargetsIndication121923_text_717136
DrugTargetsIndication121923_text_728446
DrugTargetsIndication121923_text_734764
DrugTargetsIndication121923_text_739678
DrugTargetsIndication121923_text_716356
DrugTargetsIndication121923_text_728680
DrugTargetsIndication121923_text_714718
DrugTargetsIndication121923_text_720100
DrugTargetsIndication121923_text_726028
DrugTargetsIndication121923_text_742252
DrugTargetsIndication121923_text_718540
DrugTargetsIndication121923_text_730006
DrugTargetsIndication121923_text_738274
DrugTargetsIndication121923_text_733984
DrugTargetsIndication121923_text_725482
DrugTargetsIndication121923_text_736012
DrugTargetsIndication121923_text_724156
DrugTargetsIndication121923_text_732190
DrugTargetsIndication121923_text_721738
DrugTargetsIndication121923_text_727744
DrugTargetsIndication121923_text_718462
DrugTargetsIndication121923_text_717994
DrugTargetsIndication121923_text_741862
DrugTargetsIndication121923_text_720412
DrugTargetsIndication121923_text_739912
DrugTargetsIndication121923_text_718306
DrugTargetsIndication121923_text_727432
DrugTargetsIndication121923_text_733126
DrugTargetsIndication121923_text_717292
DrugTargetsIndication121923_text_721270
DrugTargetsIndication121923_text_729460
DrugTargetsIndication121923_text_716668
DrugTargetsIndication121923_text_735622
DrugTargetsIndication121923_text_742642
DrugTargetsIndication121923_text_732268
DrugTargetsIndication121923_text_741316
DrugTargetsIndication121923_text_719164
DrugTargetsIndication121923_text_733750
DrugTargetsIndication121923_text_736558
DrugTargetsIndication121923_text_728056
DrugTargetsIndication121923_text_713470
DrugTargetsIndication121923_text_726574
DrugTargetsIndication121923_text_729616
DrugTargetsIndication121923_text_742954
DrugTargetsIndication121923_text_733282
DrugTargetsIndication121923_text_721816
DrugTargetsIndication121923_text_728914
DrugTargetsIndication121923_text_733048
DrugTargetsIndication121923_text_714640
DrugTargetsIndication121923_text_719086
DrugTargetsIndication121923_text_723298
DrugTargetsIndication121923_text_740380
DrugTargetsIndication121923_text_726652
DrugTargetsIndication121923_text_737650
DrugTargetsIndication121923_text_731098
DrugTargetsIndication121923_text_717916
DrugTargetsIndication121923_text_736324
DrugTargetsIndication121923_text_719476
DrugTargetsIndication121923_text_739366
DrugTargetsIndication121923_text_737884
DrugTargetsIndication121923_text_736402
DrugTargetsIndication121923_text_722830
DrugTargetsIndication121923_text_732892
DrugTargetsIndication121923_text_737416
DrugTargetsIndication121923_text_738352
DrugTargetsIndication121923_text_728836
DrugTargetsIndication121923_text_739054
DrugTargetsIndication121923_text_737728
DrugTargetsIndication121923_text_717058
DrugTargetsIndication121923_text_716278
DrugTargetsIndication121923_text_716512
DrugTargetsIndication121923_text_735466
DrugTargetsIndication121923_text_736636
DrugTargetsIndication121923_text_731332
DrugTargetsIndication121923_text_730630
DrugTargetsIndication121923_text_733516
DrugTargetsIndication121923_text_722674
DrugTargetsIndication121923_text_716590
DrugTargetsIndication121923_text_730942
DrugTargetsIndication121923_text_716200
DrugTargetsIndication121923_text_722206
DrugTargetsIndication121923_text_720022
DrugTargetsIndication121923_text_726184
DrugTargetsIndication121923_text_741004
DrugTargetsIndication121923_text_741784
DrugTargetsIndication121923_text_718774
DrugTargetsIndication121923_text_721192
DrugTargetsIndication121923_text_722440
DrugTargetsIndication121923_text_738664
DrugTargetsIndication121923_text_713860
DrugTargetsIndication121923_text_719320
DrugTargetsIndication121923_text_730084
DrugTargetsIndication121923_text_736246
DrugTargetsIndication121923_text_729382
DrugTargetsIndication121923_text_724702
DrugTargetsIndication121923_text_738430
DrugTargetsIndication121923_text_740224
DrugTargetsIndication121923_text_716902
DrugTargetsIndication121923_text_723532
DrugTargetsIndication121923_text_738898
DrugTargetsIndication121923_text_727588
DrugTargetsIndication121923_text_728368
DrugTargetsIndication121923_text_713392
DrugTargetsIndication121923_text_718930
DrugTargetsIndication121923_text_719554
DrugTargetsIndication121923_text_731644
DrugTargetsIndication121923_text_738976
DrugTargetsIndication121923_text_740614
DrugTargetsIndication121923_text_718852
DrugTargetsIndication121923_text_740692
DrugTargetsIndication121923_text_720958
DrugTargetsIndication121923_text_722518
DrugTargetsIndication121923_text_734686
DrugTargetsIndication121923_text_735232
DrugTargetsIndication121923_text_738586
DrugTargetsIndication121923_text_713782
DrugTargetsIndication121923_text_725794
DrugTargetsIndication121923_text_723766
DrugTargetsIndication121923_text_732736
DrugTargetsIndication121923_text_740302
DrugTargetsIndication121923_text_713938
DrugTargetsIndication121923_text_733906
DrugTargetsIndication121923_text_740068
DrugTargetsIndication121923_text_733204
DrugTargetsIndication121923_text_737806
DrugTargetsIndication121923_text_743032
DrugTargetsIndication121923_text_728212
DrugTargetsIndication121923_text_734530
DrugTargetsIndication121923_text_739990
DrugTargetsIndication121923_text_741082
DrugTargetsIndication121923_text_741238
DrugTargetsIndication121923_text_716824
DrugTargetsIndication121923_text_715108
DrugTargetsIndication121923_text_719710
DrugTargetsIndication121923_text_724780
DrugTargetsIndication121923_text_728602
DrugTargetsIndication121923_text_726730
DrugTargetsIndication121923_text_727666
DrugTargetsIndication121923_text_737572
DrugTargetsIndication121923_text_732346
DrugTargetsIndication121923_text_742876
DrugTargetsIndication121923_text_727510
DrugTargetsIndication121923_text_742096
DrugTargetsIndication121923_text_735700
DrugTargetsIndication121923_text_724078
DrugTargetsIndication121923_text_740146
DrugTargetsIndication121923_text_729070
DrugTargetsIndication121923_text_739132
DrugTargetsIndication121923_text_741706
DrugTargetsIndication121923_text_730708
DrugTargetsIndication121923_text_733672
DrugTargetsIndication121923_text_736948
DrugTargetsIndication121923_text_739756
DrugTargetsIndication121923_text_736090
DrugTargetsIndication121923_text_736168
DrugTargetsIndication121923_text_722050
DrugTargetsIndication121923_text_724312
DrugTargetsIndication121923_text_741160
DrugTargetsIndication121923_text_741940
DrugTargetsIndication121923_text_714952
DrugTargetsIndication121923_text_717526
DrugTargetsIndication121923_text_719242
DrugTargetsIndication121923_text_720334
DrugTargetsIndication121923_text_727822
DrugTargetsIndication121923_text_726964
DrugTargetsIndication121923_text_727042
DrugTargetsIndication121923_text_736480
DrugTargetsIndication121923_text_720646
DrugTargetsIndication121923_text_733438
DrugTargetsIndication121923_text_717448
DrugTargetsIndication121923_text_726496
DrugTargetsIndication121923_text_725716
DrugTargetsIndication121923_text_723376
DrugTargetsIndication121923_text_718696
DrugTargetsIndication121923_text_723142
DrugTargetsIndication121923_text_714562
DrugTargetsIndication121923_text_738196
DrugTargetsIndication121923_text_721036
DrugTargetsIndication121923_text_741550
DrugTargetsIndication121923_text_715966
DrugTargetsIndication121923_text_720802
DrugTargetsIndication121923_text_713236
DrugTargetsIndication121923_text_717838
DrugTargetsIndication121923_text_724936
DrugTargetsIndication121923_text_734374
DrugTargetsIndication121923_text_735778
DrugTargetsIndication121923_text_735856
DrugTargetsIndication121923_text_737260
DrugTargetsIndication121923_text_714328
DrugTargetsIndication121923_text_726808
DrugTargetsIndication121923_text_734608
DrugTargetsIndication121923_text_722362
DrugTargetsIndication121923_text_740458
DrugTargetsIndication121923_text_719788
DrugTargetsIndication121923_text_714874
DrugTargetsIndication121923_text_719866
DrugTargetsIndication121923_text_734218
DrugTargetsIndication121923_text_720490
DrugTargetsIndication121923_text_729928
DrugTargetsIndication121923_text_715030
DrugTargetsIndication121923_text_724234
DrugTargetsIndication121923_text_731176
DrugTargetsIndication121923_text_741394
DrugTargetsIndication121923_text_728524
DrugTargetsIndication121923_text_722986
DrugTargetsIndication121923_text_717370
DrugTargetsIndication121923_text_730864
DrugTargetsIndication121923_text_726886
DrugTargetsIndication121923_text_732970
DrugTargetsIndication121923_text_714016
DrugTargetsIndication121923_text_714250
DrugTargetsIndication121923_text_719008
DrugTargetsIndication121923_text_728134
DrugTargetsIndication121923_text_730474
DrugTargetsIndication121923_text_731410
DrugTargetsIndication121923_text_736792
DrugTargetsIndication121923_text_716746
DrugTargetsIndication121923_text_740926
DrugTargetsIndication121923_text_723220
DrugTargetsIndication121923_text_736870
DrugTargetsIndication121923_text_724624
DrugTargetsIndication121923_text_738820
DrugTargetsIndication121923_text_732658
DrugTargetsIndication121923_text_733828
DrugTargetsIndication121923_text_715342
DrugTargetsIndication121923_text_730786
DrugTargetsIndication121923_text_720724
DrugTargetsIndication121923_text_721504
DrugTargetsIndication121923_text_718228
DrugTargetsIndication121923_text_740536
DrugTargetsIndication121923_text_740848
DrugTargetsIndication121923_text_720256
DrugTargetsIndication121923_text_734296
DrugTargetsIndication121923_text_721894
DrugTargetsIndication121923_text_724468
DrugTargetsIndication121923_text_729694
DrugTargetsIndication121923_text_738118
DrugTargetsIndication121923_text_721348
DrugTargetsIndication121923_text_729538
DrugTargetsIndication121923_text_737962
DrugTargetsIndication121923_text_719632
DrugTargetsIndication121923_text_715888
DrugTargetsIndication121923_text_735310
DrugTargetsIndication121923_text_721426
DrugTargetsIndication121923_text_719944
DrugTargetsIndication121923_text_720178
DrugTargetsIndication121923_text_720568
DrugTargetsIndication121923_text_727900
DrugTargetsIndication121923_text_729772
DrugTargetsIndication121923_text_718618
DrugTargetsIndication121923_text_737182
DrugTargetsIndication121923_text_731800
DrugTargetsIndication121923_text_718150
DrugTargetsIndication121923_text_714094
DrugTargetsIndication121923_text_718072
DrugTargetsIndication121923_text_725404
DrugTargetsIndication121923_text_742564
DrugTargetsIndication121923_text_715498
DrugTargetsIndication121923_text_718384
DrugTargetsIndication121923_text_727198
DrugTargetsIndication121923_text_735154
DrugTargetsIndication121923_text_739522",7/22/2024,Maya,,Drug Gene relations; Drug Disease relations,,,,,,,,
Q38,how many mechanisms of action does the drug Brentuximab Vedotin have? ,"The drug Brentuximab Vedotin has two mechanisms of action: Tumor necrosis factor receptor superfamily member 8 inhibitor and         
Tubulin inhibitor.","DrugGeneTargets_v1_1084
DrugGeneTargets_v1_1085",08/09/2024,Maya,,Pharmacology,,,,,,,,
Q39,Are there any specific alleles within the gene CHRM3 associated with increased susceptibility to developing Alzheimer's disease?,"No, there are no alleles within the gene CHRM3 that are significantly associated with an increased susceptibility to developing Alzheimer's disease based on AD GWAS data.","AD_combo_gene_notext_UUID_1610513
AD_combo_gene_notext_UUID_1611098
AD_combo_gene_notext_UUID_1607682
AD_combo_gene_notext_UUID_1611062
AD_combo_gene_notext_UUID_1611086
AD_combo_gene_notext_UUID_1611049
AD_combo_gene_notext_UUID_1608959
AD_combo_gene_notext_UUID_1611520
AD_combo_gene_notext_UUID_1611271
AD_combo_gene_notext_UUID_1611700
AD_combo_gene_notext_UUID_1609179
AD_combo_gene_notext_UUID_1611660
AD_combo_gene_notext_UUID_1609909
AD_combo_gene_notext_UUID_1611135
AD_combo_gene_notext_UUID_1609829
AD_combo_gene_notext_UUID_1611422
AD_combo_gene_notext_UUID_1611336
AD_combo_gene_notext_UUID_1611141
AD_combo_gene_notext_UUID_1609931
AD_combo_gene_notext_UUID_1609003
AD_combo_gene_notext_UUID_1610795
AD_combo_gene_notext_UUID_1610811
AD_combo_gene_notext_UUID_1610703
AD_combo_gene_notext_UUID_1609378
AD_combo_gene_notext_UUID_1608322
AD_combo_gene_notext_UUID_1611005
AD_combo_gene_notext_UUID_1611836
AD_combo_gene_notext_UUID_1611109
AD_combo_gene_notext_UUID_1608000
AD_combo_gene_notext_UUID_1608808
AD_combo_gene_notext_UUID_1611018
AD_combo_gene_notext_UUID_1609251
AD_combo_gene_notext_UUID_1608454
AD_combo_gene_notext_UUID_1610519
AD_combo_gene_notext_UUID_1609728
AD_combo_gene_notext_UUID_1608444
AD_combo_gene_notext_UUID_1608011
AD_combo_gene_notext_UUID_1607971
AD_combo_gene_notext_UUID_1608568
AD_combo_gene_notext_UUID_1611128
AD_combo_gene_notext_UUID_1609967
AD_combo_gene_notext_UUID_1609093
AD_combo_gene_notext_UUID_1610671
AD_combo_gene_notext_UUID_1609779
AD_combo_gene_notext_UUID_1608434
AD_combo_gene_notext_UUID_1608433
AD_combo_gene_notext_UUID_1608151
AD_combo_gene_notext_UUID_1610120
AD_combo_gene_notext_UUID_1610025
AD_combo_gene_notext_UUID_1608353
AD_combo_gene_notext_UUID_1610461
AD_combo_gene_notext_UUID_1611214
AD_combo_gene_notext_UUID_1608493
AD_combo_gene_notext_UUID_1608853
AD_combo_gene_notext_UUID_1609514
AD_combo_gene_notext_UUID_1611258
AD_combo_gene_notext_UUID_1609029
AD_combo_gene_notext_UUID_1609362
AD_combo_gene_notext_UUID_1609368
AD_combo_gene_notext_UUID_1610532
AD_combo_gene_notext_UUID_1610877
AD_combo_gene_notext_UUID_1607942
AD_combo_gene_notext_UUID_1608893
AD_combo_gene_notext_UUID_1611013
AD_combo_gene_notext_UUID_1611044
AD_combo_gene_notext_UUID_1608437
AD_combo_gene_notext_UUID_1611497
AD_combo_gene_notext_UUID_1609518
AD_combo_gene_notext_UUID_1610679
AD_combo_gene_notext_UUID_1609288
AD_combo_gene_notext_UUID_1608446
AD_combo_gene_notext_UUID_1610016
AD_combo_gene_notext_UUID_1609392
AD_combo_gene_notext_UUID_1609183
AD_combo_gene_notext_UUID_1608047
AD_combo_gene_notext_UUID_1611829
AD_combo_gene_notext_UUID_1611474
AD_combo_gene_notext_UUID_1608610
AD_combo_gene_notext_UUID_1608366
AD_combo_gene_notext_UUID_1608336
AD_combo_gene_notext_UUID_1610385
AD_combo_gene_notext_UUID_1611805
AD_combo_gene_notext_UUID_1608386
AD_combo_gene_notext_UUID_1608549
AD_combo_gene_notext_UUID_1611881
AD_combo_gene_notext_UUID_1611681
AD_combo_gene_notext_UUID_1611717
AD_combo_gene_notext_UUID_1608059
AD_combo_gene_notext_UUID_1608001
AD_combo_gene_notext_UUID_1610642
AD_combo_gene_notext_UUID_1611496
AD_combo_gene_notext_UUID_1611465
AD_combo_gene_notext_UUID_1611023
AD_combo_gene_notext_UUID_1608150
AD_combo_gene_notext_UUID_1608707
AD_combo_gene_notext_UUID_1611477
AD_combo_gene_notext_UUID_1611809
AD_combo_gene_notext_UUID_1611641
AD_combo_gene_notext_UUID_1610246
AD_combo_gene_notext_UUID_1609762
AD_combo_gene_notext_UUID_1610839
AD_combo_gene_notext_UUID_1611155
AD_combo_gene_notext_UUID_1611480
AD_combo_gene_notext_UUID_1611879
AD_combo_gene_notext_UUID_1611486
AD_combo_gene_notext_UUID_1608227
AD_combo_gene_notext_UUID_1611547
AD_combo_gene_notext_UUID_1611457
AD_combo_gene_notext_UUID_1608115
AD_combo_gene_notext_UUID_1611869
AD_combo_gene_notext_UUID_1611855
AD_combo_gene_notext_UUID_1610249
AD_combo_gene_notext_UUID_1611203
AD_combo_gene_notext_UUID_1608510
AD_combo_gene_notext_UUID_1607796
AD_combo_gene_notext_UUID_1607880
AD_combo_gene_notext_UUID_1611895
AD_combo_gene_notext_UUID_1610840
AD_combo_gene_notext_UUID_1610492
AD_combo_gene_notext_UUID_1608488
AD_combo_gene_notext_UUID_1607815
AD_combo_gene_notext_UUID_1611319
AD_combo_gene_notext_UUID_1609334
AD_combo_gene_notext_UUID_1610502
AD_combo_gene_notext_UUID_1611655
AD_combo_gene_notext_UUID_1607725
AD_combo_gene_notext_UUID_1611615
AD_combo_gene_notext_UUID_1611803
AD_combo_gene_notext_UUID_1608387
AD_combo_gene_notext_UUID_1611511
AD_combo_gene_notext_UUID_1607981
AD_combo_gene_notext_UUID_1609097
AD_combo_gene_notext_UUID_1609375
AD_combo_gene_notext_UUID_1611731
AD_combo_gene_notext_UUID_1608968
AD_combo_gene_notext_UUID_1608026
AD_combo_gene_notext_UUID_1609804
AD_combo_gene_notext_UUID_1610013
AD_combo_gene_notext_UUID_1611327
AD_combo_gene_notext_UUID_1611025
AD_combo_gene_notext_UUID_1608605
AD_combo_gene_notext_UUID_1610071
AD_combo_gene_notext_UUID_1610936
AD_combo_gene_notext_UUID_1608082
AD_combo_gene_notext_UUID_1608458
AD_combo_gene_notext_UUID_1607877
AD_combo_gene_notext_UUID_1608677
AD_combo_gene_notext_UUID_1611144
AD_combo_gene_notext_UUID_1608952
AD_combo_gene_notext_UUID_1610286
AD_combo_gene_notext_UUID_1611293
AD_combo_gene_notext_UUID_1611593
AD_combo_gene_notext_UUID_1611378
AD_combo_gene_notext_UUID_1608948
AD_combo_gene_notext_UUID_1611166
AD_combo_gene_notext_UUID_1610479
AD_combo_gene_notext_UUID_1611357
AD_combo_gene_notext_UUID_1611163
AD_combo_gene_notext_UUID_1610972
AD_combo_gene_notext_UUID_1608540
AD_combo_gene_notext_UUID_1608031
AD_combo_gene_notext_UUID_1608934
AD_combo_gene_notext_UUID_1611342
AD_combo_gene_notext_UUID_1607825
AD_combo_gene_notext_UUID_1608527
AD_combo_gene_notext_UUID_1608452
AD_combo_gene_notext_UUID_1611309
AD_combo_gene_notext_UUID_1608367
AD_combo_gene_notext_UUID_1608271
AD_combo_gene_notext_UUID_1609660
AD_combo_gene_notext_UUID_1608900
AD_combo_gene_notext_UUID_1610697
AD_combo_gene_notext_UUID_1608014
AD_combo_gene_notext_UUID_1611830
AD_combo_gene_notext_UUID_1608140
AD_combo_gene_notext_UUID_1608209
AD_combo_gene_notext_UUID_1611167
AD_combo_gene_notext_UUID_1608139
AD_combo_gene_notext_UUID_1610677
AD_combo_gene_notext_UUID_1607833
AD_combo_gene_notext_UUID_1608043
AD_combo_gene_notext_UUID_1608127
AD_combo_gene_notext_UUID_1608131
AD_combo_gene_notext_UUID_1609871
AD_combo_gene_notext_UUID_1611808
AD_combo_gene_notext_UUID_1610009
AD_combo_gene_notext_UUID_1608124
AD_combo_gene_notext_UUID_1607841
AD_combo_gene_notext_UUID_1609214
AD_combo_gene_notext_UUID_1608202
AD_combo_gene_notext_UUID_1608138
AD_combo_gene_notext_UUID_1610787
AD_combo_gene_notext_UUID_1611116
AD_combo_gene_notext_UUID_1608126
AD_combo_gene_notext_UUID_1610023
AD_combo_gene_notext_UUID_1611107
AD_combo_gene_notext_UUID_1610160
AD_combo_gene_notext_UUID_1607793
AD_combo_gene_notext_UUID_1610209
AD_combo_gene_notext_UUID_1608567
AD_combo_gene_notext_UUID_1609373
AD_combo_gene_notext_UUID_1608740
AD_combo_gene_notext_UUID_1611833
AD_combo_gene_notext_UUID_1609105
AD_combo_gene_notext_UUID_1611701
AD_combo_gene_notext_UUID_1608847
AD_combo_gene_notext_UUID_1611838
AD_combo_gene_notext_UUID_1611175
AD_combo_gene_notext_UUID_1610845
AD_combo_gene_notext_UUID_1611807
AD_combo_gene_notext_UUID_1611652
AD_combo_gene_notext_UUID_1611231
AD_combo_gene_notext_UUID_1608266
AD_combo_gene_notext_UUID_1609533
AD_combo_gene_notext_UUID_1611114
AD_combo_gene_notext_UUID_1610881
AD_combo_gene_notext_UUID_1611132
AD_combo_gene_notext_UUID_1608009
AD_combo_gene_notext_UUID_1610872
AD_combo_gene_notext_UUID_1610730
AD_combo_gene_notext_UUID_1608095
AD_combo_gene_notext_UUID_1610833
AD_combo_gene_notext_UUID_1611050
AD_combo_gene_notext_UUID_1611291
AD_combo_gene_notext_UUID_1609459
AD_combo_gene_notext_UUID_1609030
AD_combo_gene_notext_UUID_1608331
AD_combo_gene_notext_UUID_1609448
AD_combo_gene_notext_UUID_1610213
AD_combo_gene_notext_UUID_1608824
AD_combo_gene_notext_UUID_1611424
AD_combo_gene_notext_UUID_1611481
AD_combo_gene_notext_UUID_1607687
AD_combo_gene_notext_UUID_1611221
AD_combo_gene_notext_UUID_1609554
AD_combo_gene_notext_UUID_1608467
AD_combo_gene_notext_UUID_1610856
AD_combo_gene_notext_UUID_1608168
AD_combo_gene_notext_UUID_1608169
AD_combo_gene_notext_UUID_1608474
AD_combo_gene_notext_UUID_1608392
AD_combo_gene_notext_UUID_1608338
AD_combo_gene_notext_UUID_1609451
AD_combo_gene_notext_UUID_1610847
AD_combo_gene_notext_UUID_1609042
AD_combo_gene_notext_UUID_1610823
AD_combo_gene_notext_UUID_1609592
AD_combo_gene_notext_UUID_1611643
AD_combo_gene_notext_UUID_1610853
AD_combo_gene_notext_UUID_1610077
AD_combo_gene_notext_UUID_1611335
AD_combo_gene_notext_UUID_1609599
AD_combo_gene_notext_UUID_1609153
AD_combo_gene_notext_UUID_1608320
AD_combo_gene_notext_UUID_1610773
AD_combo_gene_notext_UUID_1608235
AD_combo_gene_notext_UUID_1609764
AD_combo_gene_notext_UUID_1610804
AD_combo_gene_notext_UUID_1608290
AD_combo_gene_notext_UUID_1608693
AD_combo_gene_notext_UUID_1608614
AD_combo_gene_notext_UUID_1610850
AD_combo_gene_notext_UUID_1608580
AD_combo_gene_notext_UUID_1608199
AD_combo_gene_notext_UUID_1610748
AD_combo_gene_notext_UUID_1610806
AD_combo_gene_notext_UUID_1610848
AD_combo_gene_notext_UUID_1607732
AD_combo_gene_notext_UUID_1608846
AD_combo_gene_notext_UUID_1608302
AD_combo_gene_notext_UUID_1611160
AD_combo_gene_notext_UUID_1608293
AD_combo_gene_notext_UUID_1608218
AD_combo_gene_notext_UUID_1610873
AD_combo_gene_notext_UUID_1610862
AD_combo_gene_notext_UUID_1610876
AD_combo_gene_notext_UUID_1610963
AD_combo_gene_notext_UUID_1608348
AD_combo_gene_notext_UUID_1610879
AD_combo_gene_notext_UUID_1610869
AD_combo_gene_notext_UUID_1610165
AD_combo_gene_notext_UUID_1610884
AD_combo_gene_notext_UUID_1610708
AD_combo_gene_notext_UUID_1610250
AD_combo_gene_notext_UUID_1609953
AD_combo_gene_notext_UUID_1611193
AD_combo_gene_notext_UUID_1610608
AD_combo_gene_notext_UUID_1608638
AD_combo_gene_notext_UUID_1607768
AD_combo_gene_notext_UUID_1611848
AD_combo_gene_notext_UUID_1610925
AD_combo_gene_notext_UUID_1611788
AD_combo_gene_notext_UUID_1608257
AD_combo_gene_notext_UUID_1611284
AD_combo_gene_notext_UUID_1607982
AD_combo_gene_notext_UUID_1607921
AD_combo_gene_notext_UUID_1611600
AD_combo_gene_notext_UUID_1610455
AD_combo_gene_notext_UUID_1611103
AD_combo_gene_notext_UUID_1607952
AD_combo_gene_notext_UUID_1608685
AD_combo_gene_notext_UUID_1608932
AD_combo_gene_notext_UUID_1610878
AD_combo_gene_notext_UUID_1611636
AD_combo_gene_notext_UUID_1610880
AD_combo_gene_notext_UUID_1611302
AD_combo_gene_notext_UUID_1611332
AD_combo_gene_notext_UUID_1611122
AD_combo_gene_notext_UUID_1609857
AD_combo_gene_notext_UUID_1608149
AD_combo_gene_notext_UUID_1611479
AD_combo_gene_notext_UUID_1607987
AD_combo_gene_notext_UUID_1607836
AD_combo_gene_notext_UUID_1610885
AD_combo_gene_notext_UUID_1609698
AD_combo_gene_notext_UUID_1610769
AD_combo_gene_notext_UUID_1609516
AD_combo_gene_notext_UUID_1611157
AD_combo_gene_notext_UUID_1607861
AD_combo_gene_notext_UUID_1608161
AD_combo_gene_notext_UUID_1608941
AD_combo_gene_notext_UUID_1609523
AD_combo_gene_notext_UUID_1608371
AD_combo_gene_notext_UUID_1607929
AD_combo_gene_notext_UUID_1608631
AD_combo_gene_notext_UUID_1609218
AD_combo_gene_notext_UUID_1608892
AD_combo_gene_notext_UUID_1607888
AD_combo_gene_notext_UUID_1609613
AD_combo_gene_notext_UUID_1609216
AD_combo_gene_notext_UUID_1610443
AD_combo_gene_notext_UUID_1610714
AD_combo_gene_notext_UUID_1610736
AD_combo_gene_notext_UUID_1608545
AD_combo_gene_notext_UUID_1611345
AD_combo_gene_notext_UUID_1611268
AD_combo_gene_notext_UUID_1607882
AD_combo_gene_notext_UUID_1608346
AD_combo_gene_notext_UUID_1611152
AD_combo_gene_notext_UUID_1609312
AD_combo_gene_notext_UUID_1611380
AD_combo_gene_notext_UUID_1610866
AD_combo_gene_notext_UUID_1608630
AD_combo_gene_notext_UUID_1609708
AD_combo_gene_notext_UUID_1608184
AD_combo_gene_notext_UUID_1611106
AD_combo_gene_notext_UUID_1609781
AD_combo_gene_notext_UUID_1611379
AD_combo_gene_notext_UUID_1610882
AD_combo_gene_notext_UUID_1611448
AD_combo_gene_notext_UUID_1611387
AD_combo_gene_notext_UUID_1607960
AD_combo_gene_notext_UUID_1608627
AD_combo_gene_notext_UUID_1608755
AD_combo_gene_notext_UUID_1609980
AD_combo_gene_notext_UUID_1610951
AD_combo_gene_notext_UUID_1610898
AD_combo_gene_notext_UUID_1610580
AD_combo_gene_notext_UUID_1611513
AD_combo_gene_notext_UUID_1611287
AD_combo_gene_notext_UUID_1610771
AD_combo_gene_notext_UUID_1608236
AD_combo_gene_notext_UUID_1609975
AD_combo_gene_notext_UUID_1610162
AD_combo_gene_notext_UUID_1609623
AD_combo_gene_notext_UUID_1611812
AD_combo_gene_notext_UUID_1610265
AD_combo_gene_notext_UUID_1608239
AD_combo_gene_notext_UUID_1608394
AD_combo_gene_notext_UUID_1608273
AD_combo_gene_notext_UUID_1608003
AD_combo_gene_notext_UUID_1610199
AD_combo_gene_notext_UUID_1608554
AD_combo_gene_notext_UUID_1611843
AD_combo_gene_notext_UUID_1611337
AD_combo_gene_notext_UUID_1610849
AD_combo_gene_notext_UUID_1607844
AD_combo_gene_notext_UUID_1607822
AD_combo_gene_notext_UUID_1611393
AD_combo_gene_notext_UUID_1608802
AD_combo_gene_notext_UUID_1611723
AD_combo_gene_notext_UUID_1607681
AD_combo_gene_notext_UUID_1608674
AD_combo_gene_notext_UUID_1611823
AD_combo_gene_notext_UUID_1608519
AD_combo_gene_notext_UUID_1608129
AD_combo_gene_notext_UUID_1608264
AD_combo_gene_notext_UUID_1608739
AD_combo_gene_notext_UUID_1607807
AD_combo_gene_notext_UUID_1610507
AD_combo_gene_notext_UUID_1610825
AD_combo_gene_notext_UUID_1608471
AD_combo_gene_notext_UUID_1608615
AD_combo_gene_notext_UUID_1609629
AD_combo_gene_notext_UUID_1608591
AD_combo_gene_notext_UUID_1608469
AD_combo_gene_notext_UUID_1610700
AD_combo_gene_notext_UUID_1611136
AD_combo_gene_notext_UUID_1609327
AD_combo_gene_notext_UUID_1608190
AD_combo_gene_notext_UUID_1611346
AD_combo_gene_notext_UUID_1608756
AD_combo_gene_notext_UUID_1609921
AD_combo_gene_notext_UUID_1610993
AD_combo_gene_notext_UUID_1608167
AD_combo_gene_notext_UUID_1608166
AD_combo_gene_notext_UUID_1610854
AD_combo_gene_notext_UUID_1611072
AD_combo_gene_notext_UUID_1609972
AD_combo_gene_notext_UUID_1608806
AD_combo_gene_notext_UUID_1611475
AD_combo_gene_notext_UUID_1610466
AD_combo_gene_notext_UUID_1611818
AD_combo_gene_notext_UUID_1608571
AD_combo_gene_notext_UUID_1609840
AD_combo_gene_notext_UUID_1607744
AD_combo_gene_notext_UUID_1608410
AD_combo_gene_notext_UUID_1608632
AD_combo_gene_notext_UUID_1610968
AD_combo_gene_notext_UUID_1611169
AD_combo_gene_notext_UUID_1609833
AD_combo_gene_notext_UUID_1611893
AD_combo_gene_notext_UUID_1608424
AD_combo_gene_notext_UUID_1608886
AD_combo_gene_notext_UUID_1609221
AD_combo_gene_notext_UUID_1610821
AD_combo_gene_notext_UUID_1608521
AD_combo_gene_notext_UUID_1608559
AD_combo_gene_notext_UUID_1608787
AD_combo_gene_notext_UUID_1610987
AD_combo_gene_notext_UUID_1611420
AD_combo_gene_notext_UUID_1610820
AD_combo_gene_notext_UUID_1610817
AD_combo_gene_notext_UUID_1611654
AD_combo_gene_notext_UUID_1610792
AD_combo_gene_notext_UUID_1608971
AD_combo_gene_notext_UUID_1609817
AD_combo_gene_notext_UUID_1611374
AD_combo_gene_notext_UUID_1611806
AD_combo_gene_notext_UUID_1608191
AD_combo_gene_notext_UUID_1609256
AD_combo_gene_notext_UUID_1610639
AD_combo_gene_notext_UUID_1608087
AD_combo_gene_notext_UUID_1608657
AD_combo_gene_notext_UUID_1608143
AD_combo_gene_notext_UUID_1610941
AD_combo_gene_notext_UUID_1608639
AD_combo_gene_notext_UUID_1608132
AD_combo_gene_notext_UUID_1608076
AD_combo_gene_notext_UUID_1608496
AD_combo_gene_notext_UUID_1608439
AD_combo_gene_notext_UUID_1609286
AD_combo_gene_notext_UUID_1609507
AD_combo_gene_notext_UUID_1608741
AD_combo_gene_notext_UUID_1608066
AD_combo_gene_notext_UUID_1609751
AD_combo_gene_notext_UUID_1610124
AD_combo_gene_notext_UUID_1610719
AD_combo_gene_notext_UUID_1610788
AD_combo_gene_notext_UUID_1608077
AD_combo_gene_notext_UUID_1608864
AD_combo_gene_notext_UUID_1611249
AD_combo_gene_notext_UUID_1608155
AD_combo_gene_notext_UUID_1608732
AD_combo_gene_notext_UUID_1609569
AD_combo_gene_notext_UUID_1608501
AD_combo_gene_notext_UUID_1608905
AD_combo_gene_notext_UUID_1608502
AD_combo_gene_notext_UUID_1609823
AD_combo_gene_notext_UUID_1608091
AD_combo_gene_notext_UUID_1611754
AD_combo_gene_notext_UUID_1611517
AD_combo_gene_notext_UUID_1608362
AD_combo_gene_notext_UUID_1609926
AD_combo_gene_notext_UUID_1609793
AD_combo_gene_notext_UUID_1609144
AD_combo_gene_notext_UUID_1610723
AD_combo_gene_notext_UUID_1610478
AD_combo_gene_notext_UUID_1611594
AD_combo_gene_notext_UUID_1609837
AD_combo_gene_notext_UUID_1609379
AD_combo_gene_notext_UUID_1608133
AD_combo_gene_notext_UUID_1608611
AD_combo_gene_notext_UUID_1607955
AD_combo_gene_notext_UUID_1609888
AD_combo_gene_notext_UUID_1608697
AD_combo_gene_notext_UUID_1608165
AD_combo_gene_notext_UUID_1608347
AD_combo_gene_notext_UUID_1608002
AD_combo_gene_notext_UUID_1611503
AD_combo_gene_notext_UUID_1610423
AD_combo_gene_notext_UUID_1609611
AD_combo_gene_notext_UUID_1607908
AD_combo_gene_notext_UUID_1608120
AD_combo_gene_notext_UUID_1608659
AD_combo_gene_notext_UUID_1608988
AD_combo_gene_notext_UUID_1610377
AD_combo_gene_notext_UUID_1611057
AD_combo_gene_notext_UUID_1609415
AD_combo_gene_notext_UUID_1611001",7/29/2024,Maya,,Snp disease relations; Gene disease relations ,"follow up with ad gwas once genes are listed
also listing source at end will provide context ",,,,,,,
Q40,"Are there any specific alleles within the gene CHRM3 associated with increased susceptibility to developing Alzheimer's disease, as determined by significant SMR analysis?","No, based on the blood, liver, and 
brain samples tested there are no alleles within the gene CHRM3 that are significantly associated with an increased susceptibility to developing Alzheimer's disease.","NDD_SMR_genes_all_update_text_42309
NDD_SMR_genes_all_update_text_1464887
NDD_SMR_genes_all_update_text_656801",7/22/2024,Maya,,SMR Snp disease relations; SMR Gene disease relations ,"follow up with ad gwas once genes are listed
also listing source at end will provide context ",,,,,,,
Q41,Can you discuss the expression patterns based on SMR calculations of the NSF gene and its potential role in neuroprotection against Parkinson's disease?,"The expression patterns of the NSF gene within the prefrontal cortex and whole blood suggest that NSF does play a significant protective role in Parkinson's Disease (PD). 

Blood eQTLgen:
•Top associated SNP: rs62074125
•Adjusted SMR multi-SNP P-value: 4.42e-10
•HEIDI: 1.9028e-06
        
Prefrontal Cortex eQTL
•Top associated SNP: rs3874943
•Adjusted SMR multi-SNP P-value: 4.66e-08
•HEIDI: 5.7680e-05
","NDD_SMR_genes_all_update_text_1242289
NDD_SMR_genes_all_update_text_1564795",8/23/2024,Maya,,SMR Snp disease relations; SMR Gene disease relations ,,,Can you discuss the expression patterns based on SMR calculations of the {Gene} gene and its potential role in neuroprotection against {Disease_name}?,The expression patterns of the {Gene} gene within in the {Omic_tissue} tissues of this dataset suggests that {Gene} does not play a significant protective or harmful role in {Disease_name} ({Disease}). ,"The expression patterns of the {Gene} gene within the {Omic_tissue} suggest that {Gene} does play a significant protective role in {Disease_name} ({Disease}). 

{Omic_tissue}:
•Top associated SNP: {topSNP}
•Adjusted SMR multi-SNP P-value: {p_SMR_multi} (round to 2 decimal places)
•HEIDI: {p_HEIDI} (round to 4 decimal places)
        
repeat for the top snp in each omic tissues that are signif 
",,,
Q42,What is the genomic location of SNP's rs3738435 and rs566586173 in the GRCh38/hg38 build of the human genome and what gene are they located on or near?,"The SNP rs3738435 is located on the gene CHRM3 at position 239907303 in the GRCh38/hg38 build of the human genome.
The SNP rs566586173 is located on the gene ERC1 at position 1468612 in the GRCh38/hg38 build of the human genome.
","AD_combo_gene_notext_UUID_1611832
PDno23andme_full_gene_notext_3078323
AD_combo_gene_notext_UUID_14740261",8/2/2024,Maya,,Genomic location ,,,What is the genomic location of SNP x in the GRCh38/hg38 build of the human genome and what gene is it located on or near?,"The SNP x is located on the gene y at position z in the GRCh38/hg38 build of the human genome.
",The genomic location of SNP X is unknown.,,,
Q43,What SNPs are significantly associated with Parkinson disease?,"Yes, there are 3,410 SNPs that are significantly associated with an increased risk of Parkinson's Disease. Here are the top 10 SNPs according to the largest European genome-wide meta-analysis of Parkinson's disease (Nalls et al., 2019):

• rs356203 (GWAS P-value: 3.01E-41; b value: 0.2398; nearest gene: SNCA)
• rs356219 (GWAS P-value: 3.47E-41; b value: 0.2334; nearest gene: GPRIN3;SNCA)
• rs356220 (GWAS P-value: 3.92E-41; b value: 0.2326; nearest gene: GPRIN3;SNCA)
• rs356215 (GWAS P-value: 1.01E-36; b value: 0.2197; nearest gene: GPRIN3;SNCA)
• rs356182 (GWAS P-value: 9.41E-34; b value: 0.2545; nearest gene: GPRIN3;SNCA)
• rs356225 (GWAS P-value: 2.51E-32; b value: 0.2043; nearest gene: GPRIN3;SNCA)
• rs356221 (GWAS P-value: 2.52E-32; b value: 0.2041; nearest gene: GPRIN3;SNCA)
• rs356204 (GWAS P-value: 2.87E-32; b value: 0.2085; nearest gene: SNCA)
• rs189596 (GWAS P-value: 4.29E-32; b value: 0.2093; nearest gene: SNCA)
• rs356200 (GWAS P-value: 5.61E-32; b value: 0.2084; nearest gene: SNCA)","PDno23andme_full_gene_notext_1492093
PDno23andme_full_gene_notext_4541022
PDno23andme_full_gene_notext_3029756
PDno23andme_full_gene_notext_6349215
PDno23andme_full_gene_notext_7539504
PDno23andme_full_gene_notext_153395
PDno23andme_full_gene_notext_4449871
PDno23andme_full_gene_notext_6805650
PDno23andme_full_gene_notext_7042578
PDno23andme_full_gene_notext_3240570",7/29/2024,Maya,,Snp disease relations ,,,,,,,,
Q44,Tell me about GWAS in Alzheimer's Disease.,"A Genome-wide association study (GWAS) identifys risk alleles that are associated with a particular disease. According to the largest European meta-GWAS of Alzheimer's disease (Bellenguez, 2022), there are 5,625 SNPs that were found to be significantly associated with an increased risk of Alzheimer's disease.  Here are the top 10 SNPs:

• rs117310449 (GWAS P-value: 3.26E-115; b value: 0.7701; nearest gene: TOMM40)
• rs144261139 (GWAS P-value: 5.17E-111; b value: 0.7545; nearest gene: NECTIN2)
• rs139644294 (GWAS P-value: 1.53E-94; b value: -0.2252; unspecified nearest gene)
• rs6733839 (GWAS P-value: 6.48E-90; b value: 0.1686; nearest gene: BIN1;CYP27C1)
• rs537741299 (GWAS P-value: 8.59E-84; b value: 0.8705; unspecified nearest gene)
• rs61679753 (GWAS P-value: 2.28E-83; b value: -0.5412; nearest gene: TOMM40)
• rs1160983 (GWAS P-value: 4.99E-83; b value: -0.5399; nearest gene: TOMM40)
• rs111784051 (GWAS P-value: 1.01E-82; b value: -0.5545; nearest gene: TOMM40)
• rs7254892 (GWAS P-value: 7.74E-82; b value: -0.5173; nearest gene: NECTIN2)
• rs79701229 (GWAS P-value: 5.34E-81; b value: 0.7038; nearest gene: NECTIN2)","AD_combo_gene_notext_UUID_19974366
AD_combo_gene_notext_UUID_19974311
AD_combo_gene_notext_UUID_19974435
AD_combo_gene_notext_UUID_2643372
AD_combo_gene_notext_UUID_19974502
AD_combo_gene_notext_UUID_19974414
AD_combo_gene_notext_UUID_19974389
AD_combo_gene_notext_UUID_19974428
AD_combo_gene_notext_UUID_19974343
AD_combo_gene_notext_UUID_19974306",8/23/2024,Maya,,Snp disease relations ,,,,,,,,
Q45,Is there an association between PSMF1 and Parkinson's disease?,"No, there is no significant association between PSMF1 and PD. ","PDno23andme_full_gene_notext_2456415
PDno23andme_full_gene_notext_2952100
PDno23andme_full_gene_notext_2926365
PDno23andme_full_gene_notext_2263036
PDno23andme_full_gene_notext_3771543
PDno23andme_full_gene_notext_6689033
PDno23andme_full_gene_notext_3128315
PDno23andme_full_gene_notext_4323517
PDno23andme_full_gene_notext_5880516
PDno23andme_full_gene_notext_5485058
PDno23andme_full_gene_notext_3295345
PDno23andme_full_gene_notext_2745254
PDno23andme_full_gene_notext_2321587
PDno23andme_full_gene_notext_6133822
PDno23andme_full_gene_notext_7306250
PDno23andme_full_gene_notext_7679636
PDno23andme_full_gene_notext_6410901
PDno23andme_full_gene_notext_3355819
PDno23andme_full_gene_notext_494195
PDno23andme_full_gene_notext_5093094
PDno23andme_full_gene_notext_5541509
PDno23andme_full_gene_notext_2020820
PDno23andme_full_gene_notext_6909740
PDno23andme_full_gene_notext_1260610
PDno23andme_full_gene_notext_4260559
PDno23andme_full_gene_notext_4534236
PDno23andme_full_gene_notext_867252
PDno23andme_full_gene_notext_250088
PDno23andme_full_gene_notext_933792
PDno23andme_full_gene_notext_2667811
PDno23andme_full_gene_notext_2524661
PDno23andme_full_gene_notext_5346148
PDno23andme_full_gene_notext_3884693
PDno23andme_full_gene_notext_5361384
PDno23andme_full_gene_notext_2850298
PDno23andme_full_gene_notext_5123720
PDno23andme_full_gene_notext_6243718
PDno23andme_full_gene_notext_2368679
PDno23andme_full_gene_notext_7028824
PDno23andme_full_gene_notext_1980550
PDno23andme_full_gene_notext_6936126
PDno23andme_full_gene_notext_4392027
PDno23andme_full_gene_notext_5303076
PDno23andme_full_gene_notext_792415
PDno23andme_full_gene_notext_565895
PDno23andme_full_gene_notext_4056324
PDno23andme_full_gene_notext_1214981
PDno23andme_full_gene_notext_4315788
PDno23andme_full_gene_notext_2772804
PDno23andme_full_gene_notext_6118812
PDno23andme_full_gene_notext_1076138
PDno23andme_full_gene_notext_5983201
PDno23andme_full_gene_notext_2508619
PDno23andme_full_gene_notext_2805964
PDno23andme_full_gene_notext_7299653
PDno23andme_full_gene_notext_645458
PDno23andme_full_gene_notext_3548421
PDno23andme_full_gene_notext_4225465
PDno23andme_full_gene_notext_5211366
PDno23andme_full_gene_notext_2399708
PDno23andme_full_gene_notext_4008909
PDno23andme_full_gene_notext_352984
PDno23andme_full_gene_notext_2306607
PDno23andme_full_gene_notext_439492
PDno23andme_full_gene_notext_6643236
PDno23andme_full_gene_notext_1951787
PDno23andme_full_gene_notext_4173982
PDno23andme_full_gene_notext_6147670
PDno23andme_full_gene_notext_3175726
PDno23andme_full_gene_notext_7491002
PDno23andme_full_gene_notext_6277368
PDno23andme_full_gene_notext_7641575
PDno23andme_full_gene_notext_3782548
PDno23andme_full_gene_notext_2070122
PDno23andme_full_gene_notext_5151767
PDno23andme_full_gene_notext_581158
PDno23andme_full_gene_notext_2653934
PDno23andme_full_gene_notext_6261877
PDno23andme_full_gene_notext_2659768
PDno23andme_full_gene_notext_4562455
PDno23andme_full_gene_notext_846311
PDno23andme_full_gene_notext_7635662
PDno23andme_full_gene_notext_7176199
PDno23andme_full_gene_notext_4844811
PDno23andme_full_gene_notext_3052888
PDno23andme_full_gene_notext_5474485
PDno23andme_full_gene_notext_6854069
PDno23andme_full_gene_notext_2370316
PDno23andme_full_gene_notext_3034270
PDno23andme_full_gene_notext_3677360
PDno23andme_full_gene_notext_4628982
PDno23andme_full_gene_notext_4732754
PDno23andme_full_gene_notext_1927096
PDno23andme_full_gene_notext_3154188
PDno23andme_full_gene_notext_3124150
PDno23andme_full_gene_notext_487396
PDno23andme_full_gene_notext_489443
PDno23andme_full_gene_notext_4401828
PDno23andme_full_gene_notext_5935436
PDno23andme_full_gene_notext_4918313
PDno23andme_full_gene_notext_1898477
PDno23andme_full_gene_notext_6213983
PDno23andme_full_gene_notext_1695385
PDno23andme_full_gene_notext_4073720
PDno23andme_full_gene_notext_574943
PDno23andme_full_gene_notext_3002550
PDno23andme_full_gene_notext_7690082
PDno23andme_full_gene_notext_752201
PDno23andme_full_gene_notext_5506364
PDno23andme_full_gene_notext_6876730
PDno23andme_full_gene_notext_7202923
PDno23andme_full_gene_notext_1564479
PDno23andme_full_gene_notext_2906495
PDno23andme_full_gene_notext_6253329
PDno23andme_full_gene_notext_7404616
PDno23andme_full_gene_notext_6421504
PDno23andme_full_gene_notext_3979079
PDno23andme_full_gene_notext_840335
PDno23andme_full_gene_notext_782906
PDno23andme_full_gene_notext_1212359
PDno23andme_full_gene_notext_3661279
PDno23andme_full_gene_notext_3112007
PDno23andme_full_gene_notext_1529646
PDno23andme_full_gene_notext_5444501
PDno23andme_full_gene_notext_6286318
PDno23andme_full_gene_notext_4340505
PDno23andme_full_gene_notext_772179
PDno23andme_full_gene_notext_7054458
PDno23andme_full_gene_notext_4326444
PDno23andme_full_gene_notext_7500321
PDno23andme_full_gene_notext_6340744
PDno23andme_full_gene_notext_6780682
PDno23andme_full_gene_notext_7186616
PDno23andme_full_gene_notext_7341205
PDno23andme_full_gene_notext_2385438
PDno23andme_full_gene_notext_6467057
PDno23andme_full_gene_notext_2736996
PDno23andme_full_gene_notext_3042599
PDno23andme_full_gene_notext_259033
PDno23andme_full_gene_notext_2698790
PDno23andme_full_gene_notext_103074
PDno23andme_full_gene_notext_6393852
PDno23andme_full_gene_notext_542464
PDno23andme_full_gene_notext_5599679
PDno23andme_full_gene_notext_3647764
PDno23andme_full_gene_notext_1032014",8/13/2024,Maya,,Gene disease relations ,,,,,,,,
Q46,"Based on SMR analysis, is there a significant association between PSMF1 and Parkinson's disease?","No, there is no significant association between PSMF1 and PD. ","NDD_SMR_genes_all_update_text_1243289
NDD_SMR_genes_all_update_text_1169184
NDD_SMR_genes_all_update_text_1021830
NDD_SMR_genes_all_update_text_1330012
NDD_SMR_genes_all_update_text_1281757
NDD_SMR_genes_all_update_text_1262680
NDD_SMR_genes_all_update_text_1730448
NDD_SMR_genes_all_update_text_500040
NDD_SMR_genes_all_update_text_1641095
NDD_SMR_genes_all_update_text_500039
NDD_SMR_genes_all_update_text_20464
NDD_SMR_genes_all_update_text_1437073
NDD_SMR_genes_all_update_text_1371355
NDD_SMR_genes_all_update_text_1566684
NDD_SMR_genes_all_update_text_1144479
NDD_SMR_genes_all_update_text_1021829
NDD_SMR_genes_all_update_text_500041
NDD_SMR_genes_all_update_text_500036
NDD_SMR_genes_all_update_text_500037
NDD_SMR_genes_all_update_text_1021831
NDD_SMR_genes_all_update_text_500038",7/22/2024,Maya,,SMR Gene disease relations ,,,,,,,,
Q47,What types of variants within RAB32 were found to have an effect on Parkinson's disease risk?,"There are no variants within the RAB32 gene found to have an effect on Parkinson's disease risk. Therefore, no distinct types of variants within RAB32 have been identified as influencing the risk of developing PD.","PDno23andme_full_gene_notext_7423787
PDno23andme_full_gene_notext_2174453
PDno23andme_full_gene_notext_6751603
PDno23andme_full_gene_notext_3299696
PDno23andme_full_gene_notext_3629191
PDno23andme_full_gene_notext_5519119
PDno23andme_full_gene_notext_2045193
PDno23andme_full_gene_notext_6502302
PDno23andme_full_gene_notext_3627818
PDno23andme_full_gene_notext_5668826
PDno23andme_full_gene_notext_5523003
PDno23andme_full_gene_notext_1674374
PDno23andme_full_gene_notext_2891370
PDno23andme_full_gene_notext_614411
PDno23andme_full_gene_notext_2576846
PDno23andme_full_gene_notext_739125
PDno23andme_full_gene_notext_5298852
PDno23andme_full_gene_notext_2898505",7/22/2024,Maya,,Snp disease relations; Gene disease relations ,,,,,,,,
Q48,Are there any association signals with the gene ADAM10 in Alzheimer's disease?,"Yes, there are 19 SNPs that are significantly associated with the gene ADAM10 in Alzheimer's disease. Here are the top 10 SNPs in the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022):

• rs653765 (GWAS P-value: 3.44E-11; b value: -0.0599)
• rs6494035 (GWAS P-value: 4.12E-11; b value: -0.0596)
• rs12911832 (GWAS P-value: 4.17E-11; b value: -0.0601)
• rs6494036 (GWAS P-value: 4.20E-11; b value: -0.0596)
• rs6494037 (GWAS P-value: 4.44E-11; b value: -0.0595)
• rs12911961 (GWAS P-value: 6.60E-11; b value: -0.0594)
• rs12912003 (GWAS P-value: 6.78E-11; b value: -0.0593)
• rs442495 (GWAS P-value: 8.19E-11; b value: -0.057)
• rs11854073 (GWAS P-value: 1.20E-10; b value: -0.0564)
• rs2555356 (GWAS P-value: 1.51E-10; b value: -0.0561)","AD_combo_gene_notext_UUID_17447306
AD_combo_gene_notext_UUID_17447143
AD_combo_gene_notext_UUID_17446946
AD_combo_gene_notext_UUID_17447145
AD_combo_gene_notext_UUID_17447148
AD_combo_gene_notext_UUID_17446945
AD_combo_gene_notext_UUID_17446947
AD_combo_gene_notext_UUID_17447179
AD_combo_gene_notext_UUID_17446878
AD_combo_gene_notext_UUID_17447149
AD_combo_gene_notext_UUID_17447260
AD_combo_gene_notext_UUID_17446884
AD_combo_gene_notext_UUID_17447038
AD_combo_gene_notext_UUID_17446922
AD_combo_gene_notext_UUID_17446809
AD_combo_gene_notext_UUID_17446853
AD_combo_gene_notext_UUID_17446849
AD_combo_gene_notext_UUID_17446861
AD_combo_gene_notext_UUID_17446820",8/23/2024,Maya,,Snp disease relations; Gene disease relations ,,,,,,,,
Q49,Are there any SMR association signals with the gene ADAM10 in Alzheimer's disease?,"Yes, there are 3 significant SMR association signals with the gene ADAM10 in Alzheimer's disease across different tissues. Here are the SNPs and their adjusted SMR p-values:
• rs2250583
    • Whole brain tissue: Adjusted SMR multi-SNP P-value: 2.60E-06; HEIDI: 0.0779

• rs7161799
    • Whole blood eQTL data: Adjusted SMR multi-SNP P-value: 1.33E-06; HEIDI: 0.2374

• rs1427280
    • Cortex eQTL data: Adjusted SMR multi-SNP P-value: 2.62E-06; HEIDI: 0.0098","NDD_SMR_genes_all_update_text_1500785
NDD_SMR_genes_all_update_text_105563
NDD_SMR_genes_all_update_text_1109990",8/23/2024,Maya,,SMR Snp disease relations; SMR Gene disease relations ,,,,,,,,
Q50,Do GBA gene mutations increase the risk of Parkinson's disease?,"2 GBA gene mutations were found to be significantly associated with an increased risk of Parkinson's disease according to the largest European genome-wide meta-analysis of Parkinson's disease (Nalls et al., 2019):

 • rs12752133 (GWAS P-value: 4.11E-29; b value: 0.7821)
 • rs2230288 (GWAS P-value: 3.06E-28; b value: 0.7358)","PDno23andme_full_gene_notext_7007839
PDno23andme_full_gene_notext_3083751",8/23/2024,Maya,,Snp disease relations; Gene disease relations ,,,,,,,,
Q51,What is the relevance of the gene TREM2 in Alzheimer's disease?,"2 TREM2 SNPs were found to be significantly associated with an increased risk of Alzheimer's disease. Here are the top SNPs according to the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022):
 • rs75932628 (GWAS P-value: 1.39E-27; b value: 0.8843)
 • rs143332484 (GWAS P-value: 6.04E-19; b value: 0.3346)","AD_combo_gene_notext_UUID_8300440
AD_combo_gene_notext_UUID_8300439
",8/23/2024,Maya,,Gene disease relations ,,,,,,,,
Q52,What is the relevance of the gene TREM2 in Alzheimer's disease using SMR calculations?,"1 TREM2 SNP was found to be significant in Alzheimer's disease in the cortex:
• rs9394778
    • Cortex: Adjusted SMR multi-SNP P-value: 6.31E-07; HEIDI: 0.7033",NDD_SMR_genes_all_update_text_1109138,8/23/2024,Maya,,SMR Gene disease relations ,,,,,,,,
Q53,Is there a statistically significant association between any APOE SNPs and Alzheimer's Disease?,"Yes, the APOE gene is widely recognized as a major genetic risk factor for Alzheimer's Disease. Here are the 5 significant SNPs in the largest European genome-wide meta-analysis of Alzheimer's disease (Bellenguez, 2022):
        •        rs1081106 (GWAS P-value: 7.20E-34; b value: -0.2024)
        •        rs769446 (GWAS P-value: 4.23E-31; b value: -0.1889)
        •        rs769452 (GWAS P-value: 7.49E-18; b value: 0.7199)
        •        rs769448 (GWAS P-value: 7.81E-14; b value: -0.2474)
        •        rs439382 (GWAS P-value: 2.93E-11; b value: 0.9696)","AD_combo_gene_notext_UUID_19908970
AD_combo_gene_notext_UUID_19908949
AD_combo_gene_notext_UUID_19908960
AD_combo_gene_notext_UUID_19908952
AD_combo_gene_notext_UUID_19908948",8/23/2024,Maya,,Snp disease relations; Gene disease relations ,,,,,,,,
Q54,Is CCDC93 associated with AD in tibial nerves? ,The expression patterns of the CCDC93 gene in the tibial nerve suggests that CCDC93 does not play a significant role in Alzheimer's Disease.,NDD_SMR_genes_all_update_text_1285358,7/9/2024,Maya,,SMR Gene disease relations; Tissue,,,,,,,,
Q55,"Based on blood eQTL data, what is the top SNP in SNCA that is associated with Parkinson's disease (PD), and what is its adjusted SMR p-value?","SNCA’s top associated SNP, is rs2245801, has a multi SNP SMR p value of 9.761195e-14 and a HEIDI value of 5.974436e-15.",NDD_SMR_genes_all_update_text_1555943,Aug 6,Marzieh/Maya,,Tissue; SMR Snp disease relations; SMR Gene disease relations  ,,,,,,,,
Q56,Has any relationship been reported between EIF2B3 and Alzheimer's Disease (AD)?,"No, the gene EIF2B3 is not found to have a significant relationship in Alzheimer's disease.","AD_combo_gene_notext_UUID_336642
AD_combo_gene_notext_UUID_336813
AD_combo_gene_notext_UUID_336380
AD_combo_gene_notext_UUID_336437
AD_combo_gene_notext_UUID_336213
AD_combo_gene_notext_UUID_336577
AD_combo_gene_notext_UUID_336298
AD_combo_gene_notext_UUID_336698
AD_combo_gene_notext_UUID_336906
AD_combo_gene_notext_UUID_336209
AD_combo_gene_notext_UUID_336852
AD_combo_gene_notext_UUID_337045
AD_combo_gene_notext_UUID_336860
AD_combo_gene_notext_UUID_337152
AD_combo_gene_notext_UUID_336821
AD_combo_gene_notext_UUID_336699
AD_combo_gene_notext_UUID_337049
AD_combo_gene_notext_UUID_336665
AD_combo_gene_notext_UUID_336938
AD_combo_gene_notext_UUID_336460
AD_combo_gene_notext_UUID_337079
AD_combo_gene_notext_UUID_337078
AD_combo_gene_notext_UUID_337114
AD_combo_gene_notext_UUID_337023
AD_combo_gene_notext_UUID_336357
AD_combo_gene_notext_UUID_337133
AD_combo_gene_notext_UUID_337018
AD_combo_gene_notext_UUID_337123
AD_combo_gene_notext_UUID_336874
AD_combo_gene_notext_UUID_336226
AD_combo_gene_notext_UUID_337076
AD_combo_gene_notext_UUID_336764
AD_combo_gene_notext_UUID_336470
AD_combo_gene_notext_UUID_336960
AD_combo_gene_notext_UUID_336366
AD_combo_gene_notext_UUID_336556
AD_combo_gene_notext_UUID_336242
AD_combo_gene_notext_UUID_336565
AD_combo_gene_notext_UUID_336457
AD_combo_gene_notext_UUID_336822
AD_combo_gene_notext_UUID_336394
AD_combo_gene_notext_UUID_336517
AD_combo_gene_notext_UUID_336915
AD_combo_gene_notext_UUID_336949
AD_combo_gene_notext_UUID_336543
AD_combo_gene_notext_UUID_336995
AD_combo_gene_notext_UUID_336315
AD_combo_gene_notext_UUID_336542
AD_combo_gene_notext_UUID_336717
AD_combo_gene_notext_UUID_336667
AD_combo_gene_notext_UUID_336859
AD_combo_gene_notext_UUID_337031
AD_combo_gene_notext_UUID_336673
AD_combo_gene_notext_UUID_336319
AD_combo_gene_notext_UUID_336473
AD_combo_gene_notext_UUID_337113
AD_combo_gene_notext_UUID_337057
AD_combo_gene_notext_UUID_336392
AD_combo_gene_notext_UUID_336661
AD_combo_gene_notext_UUID_336391
AD_combo_gene_notext_UUID_336322
AD_combo_gene_notext_UUID_336638
AD_combo_gene_notext_UUID_337098
AD_combo_gene_notext_UUID_336787
AD_combo_gene_notext_UUID_336448
AD_combo_gene_notext_UUID_336263
AD_combo_gene_notext_UUID_337083
AD_combo_gene_notext_UUID_336741
AD_combo_gene_notext_UUID_336967
AD_combo_gene_notext_UUID_336442
AD_combo_gene_notext_UUID_336472
AD_combo_gene_notext_UUID_336918
AD_combo_gene_notext_UUID_336408
AD_combo_gene_notext_UUID_336689
AD_combo_gene_notext_UUID_336267
AD_combo_gene_notext_UUID_336412
AD_combo_gene_notext_UUID_336935
AD_combo_gene_notext_UUID_337027
AD_combo_gene_notext_UUID_336720
AD_combo_gene_notext_UUID_336605
AD_combo_gene_notext_UUID_336831
AD_combo_gene_notext_UUID_336703
AD_combo_gene_notext_UUID_336297
AD_combo_gene_notext_UUID_337089
AD_combo_gene_notext_UUID_336791
AD_combo_gene_notext_UUID_337046
AD_combo_gene_notext_UUID_336512
AD_combo_gene_notext_UUID_337047
AD_combo_gene_notext_UUID_336296
AD_combo_gene_notext_UUID_336400
AD_combo_gene_notext_UUID_336982
AD_combo_gene_notext_UUID_336876
AD_combo_gene_notext_UUID_336568
AD_combo_gene_notext_UUID_337090
AD_combo_gene_notext_UUID_337063
AD_combo_gene_notext_UUID_337112
AD_combo_gene_notext_UUID_336507
AD_combo_gene_notext_UUID_336240
AD_combo_gene_notext_UUID_336576
AD_combo_gene_notext_UUID_337118
AD_combo_gene_notext_UUID_337108
AD_combo_gene_notext_UUID_336688
AD_combo_gene_notext_UUID_336611
AD_combo_gene_notext_UUID_336434
AD_combo_gene_notext_UUID_336321
AD_combo_gene_notext_UUID_336644
AD_combo_gene_notext_UUID_337039
AD_combo_gene_notext_UUID_336753
AD_combo_gene_notext_UUID_337072
AD_combo_gene_notext_UUID_337149
AD_combo_gene_notext_UUID_337000
AD_combo_gene_notext_UUID_336374
AD_combo_gene_notext_UUID_336870
AD_combo_gene_notext_UUID_336402
AD_combo_gene_notext_UUID_336693
AD_combo_gene_notext_UUID_337025
AD_combo_gene_notext_UUID_336992
AD_combo_gene_notext_UUID_336669
AD_combo_gene_notext_UUID_336643
AD_combo_gene_notext_UUID_336940
AD_combo_gene_notext_UUID_336344
AD_combo_gene_notext_UUID_337001
AD_combo_gene_notext_UUID_336592
AD_combo_gene_notext_UUID_336748
AD_combo_gene_notext_UUID_337095
AD_combo_gene_notext_UUID_336236
AD_combo_gene_notext_UUID_336913
AD_combo_gene_notext_UUID_336260
AD_combo_gene_notext_UUID_336740
AD_combo_gene_notext_UUID_336534
AD_combo_gene_notext_UUID_336541
AD_combo_gene_notext_UUID_336768
AD_combo_gene_notext_UUID_336612
AD_combo_gene_notext_UUID_336878
AD_combo_gene_notext_UUID_336757
AD_combo_gene_notext_UUID_337019
AD_combo_gene_notext_UUID_336433
AD_combo_gene_notext_UUID_336594
AD_combo_gene_notext_UUID_336469
AD_combo_gene_notext_UUID_337071
AD_combo_gene_notext_UUID_336346
AD_combo_gene_notext_UUID_336690
AD_combo_gene_notext_UUID_336837
AD_combo_gene_notext_UUID_336948
AD_combo_gene_notext_UUID_336608
AD_combo_gene_notext_UUID_336540
AD_combo_gene_notext_UUID_336630
AD_combo_gene_notext_UUID_336547
AD_combo_gene_notext_UUID_336509
AD_combo_gene_notext_UUID_336562
AD_combo_gene_notext_UUID_336571
AD_combo_gene_notext_UUID_336513
AD_combo_gene_notext_UUID_336485
AD_combo_gene_notext_UUID_336224
AD_combo_gene_notext_UUID_336423
AD_combo_gene_notext_UUID_336892
AD_combo_gene_notext_UUID_336385
AD_combo_gene_notext_UUID_336291
AD_combo_gene_notext_UUID_336439
AD_combo_gene_notext_UUID_336481
AD_combo_gene_notext_UUID_336386
AD_combo_gene_notext_UUID_336500
AD_combo_gene_notext_UUID_336566
AD_combo_gene_notext_UUID_336758
AD_combo_gene_notext_UUID_336249
AD_combo_gene_notext_UUID_336554
AD_combo_gene_notext_UUID_336928
AD_combo_gene_notext_UUID_336218
AD_combo_gene_notext_UUID_336890
AD_combo_gene_notext_UUID_336782
AD_combo_gene_notext_UUID_336817
AD_combo_gene_notext_UUID_337074
AD_combo_gene_notext_UUID_336257
AD_combo_gene_notext_UUID_337105
AD_combo_gene_notext_UUID_336572
AD_combo_gene_notext_UUID_336334
AD_combo_gene_notext_UUID_336774
AD_combo_gene_notext_UUID_336911
AD_combo_gene_notext_UUID_336617
AD_combo_gene_notext_UUID_336596
AD_combo_gene_notext_UUID_336432
AD_combo_gene_notext_UUID_336521
AD_combo_gene_notext_UUID_336328
AD_combo_gene_notext_UUID_336205
AD_combo_gene_notext_UUID_336381
AD_combo_gene_notext_UUID_336546
AD_combo_gene_notext_UUID_337128
AD_combo_gene_notext_UUID_336452
AD_combo_gene_notext_UUID_336453
AD_combo_gene_notext_UUID_336445
AD_combo_gene_notext_UUID_336250
AD_combo_gene_notext_UUID_336235
AD_combo_gene_notext_UUID_336219
AD_combo_gene_notext_UUID_336529
AD_combo_gene_notext_UUID_336373
AD_combo_gene_notext_UUID_336510
AD_combo_gene_notext_UUID_336755
AD_combo_gene_notext_UUID_336780
AD_combo_gene_notext_UUID_336545
AD_combo_gene_notext_UUID_336716
AD_combo_gene_notext_UUID_336675
AD_combo_gene_notext_UUID_336399
AD_combo_gene_notext_UUID_336908
AD_combo_gene_notext_UUID_336494
AD_combo_gene_notext_UUID_336486
AD_combo_gene_notext_UUID_336970
AD_combo_gene_notext_UUID_336271
AD_combo_gene_notext_UUID_336505
AD_combo_gene_notext_UUID_336278
AD_combo_gene_notext_UUID_336388
AD_combo_gene_notext_UUID_336361
AD_combo_gene_notext_UUID_336903
AD_combo_gene_notext_UUID_336446
AD_combo_gene_notext_UUID_336745
AD_combo_gene_notext_UUID_336280
AD_combo_gene_notext_UUID_336281
AD_combo_gene_notext_UUID_336266
AD_combo_gene_notext_UUID_336522
AD_combo_gene_notext_UUID_337066
AD_combo_gene_notext_UUID_336329
AD_combo_gene_notext_UUID_336243
AD_combo_gene_notext_UUID_336752
AD_combo_gene_notext_UUID_336786
AD_combo_gene_notext_UUID_336800
AD_combo_gene_notext_UUID_336704
AD_combo_gene_notext_UUID_336662
AD_combo_gene_notext_UUID_336616
AD_combo_gene_notext_UUID_336217
AD_combo_gene_notext_UUID_336426
AD_combo_gene_notext_UUID_336742
AD_combo_gene_notext_UUID_336816
AD_combo_gene_notext_UUID_336739
AD_combo_gene_notext_UUID_336290
AD_combo_gene_notext_UUID_336320
AD_combo_gene_notext_UUID_336648
AD_combo_gene_notext_UUID_336234
AD_combo_gene_notext_UUID_336941
AD_combo_gene_notext_UUID_337044
AD_combo_gene_notext_UUID_336701
AD_combo_gene_notext_UUID_336664
AD_combo_gene_notext_UUID_336674
AD_combo_gene_notext_UUID_336833
AD_combo_gene_notext_UUID_336828
AD_combo_gene_notext_UUID_336807
AD_combo_gene_notext_UUID_336499
AD_combo_gene_notext_UUID_336427
AD_combo_gene_notext_UUID_336520
AD_combo_gene_notext_UUID_337013
AD_combo_gene_notext_UUID_336449
AD_combo_gene_notext_UUID_336769
AD_combo_gene_notext_UUID_336922
AD_combo_gene_notext_UUID_336526
AD_combo_gene_notext_UUID_336696
AD_combo_gene_notext_UUID_336798
AD_combo_gene_notext_UUID_336801
AD_combo_gene_notext_UUID_336843
AD_combo_gene_notext_UUID_336684
AD_combo_gene_notext_UUID_336936
AD_combo_gene_notext_UUID_336244
AD_combo_gene_notext_UUID_336365
AD_combo_gene_notext_UUID_336680
AD_combo_gene_notext_UUID_337034
AD_combo_gene_notext_UUID_336920
AD_combo_gene_notext_UUID_336649
AD_combo_gene_notext_UUID_336355
AD_combo_gene_notext_UUID_336614
AD_combo_gene_notext_UUID_336371
AD_combo_gene_notext_UUID_336370
AD_combo_gene_notext_UUID_336327
AD_combo_gene_notext_UUID_336255
AD_combo_gene_notext_UUID_336585
AD_combo_gene_notext_UUID_337138
AD_combo_gene_notext_UUID_336248
AD_combo_gene_notext_UUID_336401
AD_combo_gene_notext_UUID_336559
AD_combo_gene_notext_UUID_336588
AD_combo_gene_notext_UUID_336552
AD_combo_gene_notext_UUID_336454
AD_combo_gene_notext_UUID_336835
AD_combo_gene_notext_UUID_336558
AD_combo_gene_notext_UUID_336252
AD_combo_gene_notext_UUID_336489
AD_combo_gene_notext_UUID_337147
AD_combo_gene_notext_UUID_336307
AD_combo_gene_notext_UUID_336830
AD_combo_gene_notext_UUID_336863
AD_combo_gene_notext_UUID_336259
AD_combo_gene_notext_UUID_336407
AD_combo_gene_notext_UUID_336954
AD_combo_gene_notext_UUID_336767
AD_combo_gene_notext_UUID_336678
AD_combo_gene_notext_UUID_336279
AD_combo_gene_notext_UUID_336274
AD_combo_gene_notext_UUID_336953
AD_combo_gene_notext_UUID_336461
AD_combo_gene_notext_UUID_336848
AD_combo_gene_notext_UUID_336375
AD_combo_gene_notext_UUID_336422
AD_combo_gene_notext_UUID_336294
AD_combo_gene_notext_UUID_336610
AD_combo_gene_notext_UUID_336282
AD_combo_gene_notext_UUID_336411
AD_combo_gene_notext_UUID_336569
AD_combo_gene_notext_UUID_336387
AD_combo_gene_notext_UUID_336265
AD_combo_gene_notext_UUID_336993
AD_combo_gene_notext_UUID_336206
AD_combo_gene_notext_UUID_336551
AD_combo_gene_notext_UUID_336270
AD_combo_gene_notext_UUID_336550
AD_combo_gene_notext_UUID_336393
AD_combo_gene_notext_UUID_336466
AD_combo_gene_notext_UUID_336883
AD_combo_gene_notext_UUID_336836
AD_combo_gene_notext_UUID_336288
AD_combo_gene_notext_UUID_336733
AD_combo_gene_notext_UUID_336491
AD_combo_gene_notext_UUID_336734
AD_combo_gene_notext_UUID_336519
AD_combo_gene_notext_UUID_337009
AD_combo_gene_notext_UUID_336363
AD_combo_gene_notext_UUID_336198
AD_combo_gene_notext_UUID_336293
AD_combo_gene_notext_UUID_336313
AD_combo_gene_notext_UUID_336666
AD_combo_gene_notext_UUID_336567
AD_combo_gene_notext_UUID_336555
AD_combo_gene_notext_UUID_336276
AD_combo_gene_notext_UUID_336927
AD_combo_gene_notext_UUID_336301
AD_combo_gene_notext_UUID_336233
AD_combo_gene_notext_UUID_336444
AD_combo_gene_notext_UUID_336458
AD_combo_gene_notext_UUID_336511
AD_combo_gene_notext_UUID_336503
AD_combo_gene_notext_UUID_336506
AD_combo_gene_notext_UUID_336435
AD_combo_gene_notext_UUID_336441
AD_combo_gene_notext_UUID_336725
AD_combo_gene_notext_UUID_336578
AD_combo_gene_notext_UUID_336364
AD_combo_gene_notext_UUID_337070
AD_combo_gene_notext_UUID_336514
AD_combo_gene_notext_UUID_336428
AD_combo_gene_notext_UUID_336518
AD_combo_gene_notext_UUID_336337
AD_combo_gene_notext_UUID_336275
AD_combo_gene_notext_UUID_337004
AD_combo_gene_notext_UUID_336637
AD_combo_gene_notext_UUID_336447
AD_combo_gene_notext_UUID_336985
AD_combo_gene_notext_UUID_336342
AD_combo_gene_notext_UUID_336372
AD_combo_gene_notext_UUID_336241
AD_combo_gene_notext_UUID_336349
AD_combo_gene_notext_UUID_336340
AD_combo_gene_notext_UUID_336952
AD_combo_gene_notext_UUID_336573
AD_combo_gene_notext_UUID_336268
AD_combo_gene_notext_UUID_337041
AD_combo_gene_notext_UUID_336904
AD_combo_gene_notext_UUID_336498
AD_combo_gene_notext_UUID_337051
AD_combo_gene_notext_UUID_337050
AD_combo_gene_notext_UUID_336584
AD_combo_gene_notext_UUID_336324
AD_combo_gene_notext_UUID_337119
AD_combo_gene_notext_UUID_336225
AD_combo_gene_notext_UUID_337124
AD_combo_gene_notext_UUID_337131
AD_combo_gene_notext_UUID_336261
AD_combo_gene_notext_UUID_336314
AD_combo_gene_notext_UUID_337097
AD_combo_gene_notext_UUID_337053
AD_combo_gene_notext_UUID_337055
AD_combo_gene_notext_UUID_337132
AD_combo_gene_notext_UUID_336287
AD_combo_gene_notext_UUID_337092
AD_combo_gene_notext_UUID_337037
AD_combo_gene_notext_UUID_336950
AD_combo_gene_notext_UUID_337067
AD_combo_gene_notext_UUID_336353
AD_combo_gene_notext_UUID_336539
AD_combo_gene_notext_UUID_337042
AD_combo_gene_notext_UUID_336530
AD_combo_gene_notext_UUID_337060
AD_combo_gene_notext_UUID_336544
AD_combo_gene_notext_UUID_337073
AD_combo_gene_notext_UUID_336923
AD_combo_gene_notext_UUID_337061
AD_combo_gene_notext_UUID_337106
AD_combo_gene_notext_UUID_336977
AD_combo_gene_notext_UUID_337129
AD_combo_gene_notext_UUID_337107
AD_combo_gene_notext_UUID_337139
AD_combo_gene_notext_UUID_337130
AD_combo_gene_notext_UUID_336615
AD_combo_gene_notext_UUID_337111
AD_combo_gene_notext_UUID_337136
AD_combo_gene_notext_UUID_337082
AD_combo_gene_notext_UUID_337059
AD_combo_gene_notext_UUID_337065
AD_combo_gene_notext_UUID_337056
AD_combo_gene_notext_UUID_337091
AD_combo_gene_notext_UUID_337077
AD_combo_gene_notext_UUID_336972
AD_combo_gene_notext_UUID_337103
AD_combo_gene_notext_UUID_336983
AD_combo_gene_notext_UUID_336955
AD_combo_gene_notext_UUID_336647
AD_combo_gene_notext_UUID_336932
AD_combo_gene_notext_UUID_336899
AD_combo_gene_notext_UUID_336958
AD_combo_gene_notext_UUID_336283
AD_combo_gene_notext_UUID_336984
AD_combo_gene_notext_UUID_336937
AD_combo_gene_notext_UUID_336345
AD_combo_gene_notext_UUID_336390
AD_combo_gene_notext_UUID_337100
AD_combo_gene_notext_UUID_337127
AD_combo_gene_notext_UUID_336994
AD_combo_gene_notext_UUID_336528
AD_combo_gene_notext_UUID_336998
AD_combo_gene_notext_UUID_336942
AD_combo_gene_notext_UUID_336981
AD_combo_gene_notext_UUID_336943
AD_combo_gene_notext_UUID_336700
AD_combo_gene_notext_UUID_336926
AD_combo_gene_notext_UUID_336377
AD_combo_gene_notext_UUID_336924
AD_combo_gene_notext_UUID_337036
AD_combo_gene_notext_UUID_336916
AD_combo_gene_notext_UUID_336946
AD_combo_gene_notext_UUID_336975
AD_combo_gene_notext_UUID_336910
AD_combo_gene_notext_UUID_336933
AD_combo_gene_notext_UUID_337085
AD_combo_gene_notext_UUID_336548
AD_combo_gene_notext_UUID_336719
AD_combo_gene_notext_UUID_336996
AD_combo_gene_notext_UUID_336560
AD_combo_gene_notext_UUID_336973
AD_combo_gene_notext_UUID_336582
AD_combo_gene_notext_UUID_337094
AD_combo_gene_notext_UUID_336564
AD_combo_gene_notext_UUID_336921
AD_combo_gene_notext_UUID_336875
AD_combo_gene_notext_UUID_336796
AD_combo_gene_notext_UUID_336262
AD_combo_gene_notext_UUID_336959
AD_combo_gene_notext_UUID_336871
AD_combo_gene_notext_UUID_336230
AD_combo_gene_notext_UUID_336619
AD_combo_gene_notext_UUID_336987
AD_combo_gene_notext_UUID_337110
AD_combo_gene_notext_UUID_336405
AD_combo_gene_notext_UUID_337029
AD_combo_gene_notext_UUID_337080
AD_combo_gene_notext_UUID_336806
AD_combo_gene_notext_UUID_336825
AD_combo_gene_notext_UUID_336430
AD_combo_gene_notext_UUID_336838
AD_combo_gene_notext_UUID_336919
AD_combo_gene_notext_UUID_336310
AD_combo_gene_notext_UUID_336655
AD_combo_gene_notext_UUID_336744
AD_combo_gene_notext_UUID_336804
AD_combo_gene_notext_UUID_336961
AD_combo_gene_notext_UUID_336809
AD_combo_gene_notext_UUID_336238
AD_combo_gene_notext_UUID_336795
AD_combo_gene_notext_UUID_336292
AD_combo_gene_notext_UUID_336483
AD_combo_gene_notext_UUID_336812
AD_combo_gene_notext_UUID_336826
AD_combo_gene_notext_UUID_336326
AD_combo_gene_notext_UUID_336856
AD_combo_gene_notext_UUID_336763
AD_combo_gene_notext_UUID_337135
AD_combo_gene_notext_UUID_337142
AD_combo_gene_notext_UUID_336951
AD_combo_gene_notext_UUID_336873
AD_combo_gene_notext_UUID_336849
AD_combo_gene_notext_UUID_336633
AD_combo_gene_notext_UUID_336590
AD_combo_gene_notext_UUID_336759
AD_combo_gene_notext_UUID_336718
AD_combo_gene_notext_UUID_336847
AD_combo_gene_notext_UUID_336819
AD_combo_gene_notext_UUID_336352
AD_combo_gene_notext_UUID_336747
AD_combo_gene_notext_UUID_336756
AD_combo_gene_notext_UUID_336790
AD_combo_gene_notext_UUID_337003
AD_combo_gene_notext_UUID_336397
AD_combo_gene_notext_UUID_337088
AD_combo_gene_notext_UUID_336857
AD_combo_gene_notext_UUID_336792
AD_combo_gene_notext_UUID_336761
AD_combo_gene_notext_UUID_336488",7/29/2024,Maya,,Gene disease relations ,,,,,,,,
Q57,Has any SMR relationship been reported between EIF2B3 and Alzheimer's Disease (AD)?,"No, based on omic data from cortex, putamen basal ganglia, nucleus accumbens basal ganglia, whole blood, whole brain, and prefrontal cortex tissues, the gene EIF2B3 is not found to have a functionally significant role in Alzheimer's disease.","NDD_SMR_genes_all_update_text_1104733 NDD_SMR_genes_all_update_text_1582221 NDD_SMR_genes_all_update_text_1714909 NDD_SMR_genes_all_update_text_1490276 NDD_SMR_genes_all_update_text_37340 NDD_SMR_genes_all_update_text_37341  NDD_SMR_genes_all_update_text_1194963
NDD_SMR_genes_all_update_text_37342 NDD_SMR_genes_all_update_text_1605096 NDD_SMR_genes_all_update_text_1244112 NDD_SMR_genes_all_update_text_652156 NDD_SMR_genes_all_update_text_1389059",6/27/2024 revised July 3th,Marzieh,,SMR Gene disease relations ,,,,,,,,
Q58,How many genes does the drug Sontuzumab target and what are they? ,MUC1 is the only gene target of the drug Sontuzumab.,DrugGeneTargets_v1_4993,Aug 16,Marzieh/Maya,,Drug Gene relations,,,,,,,,
Q59,"What is the genetic target of the antibody drug Bectumomab, and what is its status in clinical trials and FDA approval?",The genetic target of the antibody drug Bectumomab is CD22. Bectumomab reached phase 3 clinical trials but is not approved by the FDA for treatment of any disease.,DrugGeneTargets_v1_5503,Aug 6,Marzieh/Maya,,Drug meta; Drug Gene relations,,,,,,,,
Q60,What are the synonymous names of the drug Flanvotumab?,"Flanvotumab has the associated synonyms 20-D-7S, 20D7S, IMC-20D7S, and IMC20D7S",DrugGeneTargets_text_12843,6/27/2024 revised July 3th,Marzieh,,Drug meta,,,,,,,,
Q61,What is the chemblId of the drug Naminidil?,The chemblId for the drug Naminidil is CHEMBL2105160.,DrugGeneTargets_v1_4992,8/6/2024,Maya,,Drug meta,,,,,,,,
Q62,What are the genetic targets of the drug Halothane?,"Halothane has several genetic targets, such as KCNK2, KCNK9, KCNK18, KCNK10, KCNK3, GLRA1, GLRB, GABRA1, GABRB2, GABRG2, GABRB3, GABRA4, GABRG3, GABRQ, GABRA3, GABRP, GABRD, GABRG1, GABRB1, GABRE, GABRA2, GABRA5, and GABRA6",DrugGeneTargets_v1_5037                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5038                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5039                                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_5040                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5041                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_5042                                                                                                                                                                                                                                                                                       DrugGeneTargets_v1_5043,6/27/2024 revised July 3th,Marzieh,,Drug Gene relations,,,,,,,,
Q63,What is the maximum clinical trial phase for the drug Halothane?,Halothane reached phase 4 clinical trials.,DrugGeneTargets_v1_5037                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5038                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5039                                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_5040                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5041                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_5042                                                                                                                                                                                                                                                                                       DrugGeneTargets_v1_5043,6/27/2024 revised July 3th,Marzieh,,Drug meta,,,,,,,,
Q64,What other forms are there of the drug Chlorothiazide?,"There is one alternative form which is Chlorothiazide Sodium, the sodium salt form of Chlorothiazide.","DrugGeneTargets_v1_5405
DrugGeneTargets_v1_4705",8/9/2024,Maya,,Drug forms,,,,,,,,
Q65,"What type of molecule is Halothane, and what is its action type?","Halothane is a small molecule drug that acts as an opener, a positive allosteric modulator, and a positive modulator.",DrugGeneTargets_v1_5037                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5038                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5039                                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_5040                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5041                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_5042                                                                                                                                                                                                                                                                                       DrugGeneTargets_v1_5043,6/27/2024 revised July 3th,Marzieh,,Pharmacology,,,,,,,,
Q66,Is Halothane associated with any diseases?,"No, based on the data so far, Halothane is not associated with any diseases",DrugGeneTargets_v1_5037                                                                                                                                                                                                                                                                                         DrugGeneTargets_v1_5038                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5039                                                                                                                                                                                                                                                                                                          DrugGeneTargets_v1_5040                                                                                                                                                                                                                                                                                      DrugGeneTargets_v1_5041                                                                                                                                                                                                                                                                                        DrugGeneTargets_v1_5042                                                                                                                                                                                                                                                                                       DrugGeneTargets_v1_5043,6/27/2024 revised July 3th,Marzieh,,Drug Disease relations,,,,,,,,
Q67,What is the top-associated SNP of the gene EMID2 in whole brain eQTL omic data for LBD disease and is it functionally significant?,"The top-associated SNP for EMID2 in whole brain eQTL omic data for LBD disease is rs7805075, which has a multi-SNP SMR p-value of 0.8006395 and a HEIDI value of 0.7130096, and is not functionally significant.",NDD_SMR_genes_all_update_text_1629820,6/27/2024 revised July 3th,Marzieh,,SMR Snp disease relations; SMR Gene disease relations ,,,,,,,,
Q68,Is there any basal ganglia eQTL omic data available for the gene ZNF257 in relation to ALS (Amyotrophic Lateral Sclerosis) disease?,"Yes, there is Basal Ganglia eQTL omic data for the gene ZNF257, which indicates it does not have a functionally significant role in Amyotrophic Lateral Sclerosis.",NDD_SMR_genes_all_update_text_25257,6/27/2024 revised July 3th,Marzieh,,Tissue; Gene disease relations ,,,,,,,,
Q69,What is the nearest gene to SNP rs12483639?,The nearest gene to SNP rs12483639 is APP.,PDno23andme_full_gene_notext_4687626,July 3th,Marzieh/Maya,,Genomic location,,,,,,,,
Q70,What is the position of rs12483639 in GRCh37 and GRCh38?,The position of this SNP is 27442372 in GRCh37 and 26070056 in GRCh38.,"PDno23andme_full_gene_notext_4687626
AD_combo_gene_notext_UUID_20681288",7/29/2024,Marzieh/Maya,,Genomic location,,,,,,,,
Q71,What is the typical drug action type used by antibody therapies?,Antibody therapies most often act as inhibitors. ,"DrugGeneTargets_v1_2498
DrugGeneTargets_v1_1591
DrugGeneTargets_v1_2768
DrugGeneTargets_v1_2895
DrugGeneTargets_v1_2934
DrugGeneTargets_v1_4244
DrugGeneTargets_v1_629
DrugGeneTargets_v1_844
DrugGeneTargets_v1_51
DrugGeneTargets_v1_941
DrugGeneTargets_v1_2501
DrugGeneTargets_v1_2861
DrugGeneTargets_v1_2894
DrugGeneTargets_v1_3006
DrugGeneTargets_v1_3581
DrugGeneTargets_v1_3890
DrugGeneTargets_v1_4397
DrugGeneTargets_v1_4899
DrugGeneTargets_v1_5392
DrugGeneTargets_v1_5539
DrugGeneTargets_v1_5969
DrugGeneTargets_v1_480
DrugGeneTargets_v1_556
DrugGeneTargets_v1_587
DrugGeneTargets_v1_1023
DrugGeneTargets_v1_1089
DrugGeneTargets_v1_1635
DrugGeneTargets_v1_1763
DrugGeneTargets_v1_1930
DrugGeneTargets_v1_2034
DrugGeneTargets_v1_2244
DrugGeneTargets_v1_2308
DrugGeneTargets_v1_2758
DrugGeneTargets_v1_3110
DrugGeneTargets_v1_3177
DrugGeneTargets_v1_3712
DrugGeneTargets_v1_3952
DrugGeneTargets_v1_3954
DrugGeneTargets_v1_4140
DrugGeneTargets_v1_5390
DrugGeneTargets_v1_6191
DrugGeneTargets_v1_6248
DrugGeneTargets_v1_10
DrugGeneTargets_v1_1151
DrugGeneTargets_v1_2293
DrugGeneTargets_v1_3611
DrugGeneTargets_v1_87
DrugGeneTargets_v1_136
DrugGeneTargets_v1_644
DrugGeneTargets_v1_936
DrugGeneTargets_v1_1054
DrugGeneTargets_v1_1210
DrugGeneTargets_v1_1343
DrugGeneTargets_v1_1451
DrugGeneTargets_v1_1482
DrugGeneTargets_v1_1821
DrugGeneTargets_v1_2084
DrugGeneTargets_v1_2173
DrugGeneTargets_v1_2289
DrugGeneTargets_v1_2363
DrugGeneTargets_v1_3186
DrugGeneTargets_v1_3429
DrugGeneTargets_v1_3613
DrugGeneTargets_v1_4246
DrugGeneTargets_v1_4439
DrugGeneTargets_v1_4722
DrugGeneTargets_v1_4785
DrugGeneTargets_v1_4790
DrugGeneTargets_v1_5094
DrugGeneTargets_v1_5210
DrugGeneTargets_v1_5324
DrugGeneTargets_v1_5391
DrugGeneTargets_v1_5686
DrugGeneTargets_v1_5814
DrugGeneTargets_v1_6156
DrugGeneTargets_v1_89
DrugGeneTargets_v1_364
DrugGeneTargets_v1_643
DrugGeneTargets_v1_833
DrugGeneTargets_v1_937
DrugGeneTargets_v1_1319
DrugGeneTargets_v1_2082
DrugGeneTargets_v1_2346
DrugGeneTargets_v1_2468
DrugGeneTargets_v1_3028
DrugGeneTargets_v1_3219
DrugGeneTargets_v1_3492
DrugGeneTargets_v1_3668
DrugGeneTargets_v1_3688
DrugGeneTargets_v1_3891
DrugGeneTargets_v1_3966
DrugGeneTargets_v1_4076
DrugGeneTargets_v1_4201
DrugGeneTargets_v1_4438
DrugGeneTargets_v1_4873
DrugGeneTargets_v1_4994
DrugGeneTargets_v1_4996
DrugGeneTargets_v1_5071
DrugGeneTargets_v1_5139
DrugGeneTargets_v1_5268
DrugGeneTargets_v1_5276
DrugGeneTargets_v1_5296
DrugGeneTargets_v1_5421
DrugGeneTargets_v1_5542
DrugGeneTargets_v1_5772
DrugGeneTargets_v1_5903
DrugGeneTargets_v1_5978
DrugGeneTargets_v1_158
DrugGeneTargets_v1_230
DrugGeneTargets_v1_2736
DrugGeneTargets_v1_4245
DrugGeneTargets_v1_4952
DrugGeneTargets_v1_6362
DrugGeneTargets_v1_1022
DrugGeneTargets_v1_1731
DrugGeneTargets_v1_2596
DrugGeneTargets_v1_3524
DrugGeneTargets_v1_3953
DrugGeneTargets_v1_5891
DrugGeneTargets_v1_1704
DrugGeneTargets_v1_3820
DrugGeneTargets_v1_4204
DrugGeneTargets_v1_4339
DrugGeneTargets_v1_5642
DrugGeneTargets_v1_5685
DrugGeneTargets_v1_681
DrugGeneTargets_v1_4648
DrugGeneTargets_v1_339
DrugGeneTargets_v1_442
DrugGeneTargets_v1_1005
DrugGeneTargets_v1_1274
DrugGeneTargets_v1_1385
DrugGeneTargets_v1_1432
DrugGeneTargets_v1_1519
DrugGeneTargets_v1_1562
DrugGeneTargets_v1_2001
DrugGeneTargets_v1_2556
DrugGeneTargets_v1_2966
DrugGeneTargets_v1_3070
DrugGeneTargets_v1_3378
DrugGeneTargets_v1_3482
DrugGeneTargets_v1_3673
DrugGeneTargets_v1_4106
DrugGeneTargets_v1_4119
DrugGeneTargets_v1_4138
DrugGeneTargets_v1_4159
DrugGeneTargets_v1_4273
DrugGeneTargets_v1_4784
DrugGeneTargets_v1_5164
DrugGeneTargets_v1_5485
DrugGeneTargets_v1_5915
DrugGeneTargets_v1_5968
DrugGeneTargets_v1_6070
DrugGeneTargets_v1_6099
DrugGeneTargets_v1_6254
DrugGeneTargets_v1_6
DrugGeneTargets_v1_243
DrugGeneTargets_v1_421
DrugGeneTargets_v1_537
DrugGeneTargets_v1_850
DrugGeneTargets_v1_1159
DrugGeneTargets_v1_1426
DrugGeneTargets_v1_1707
DrugGeneTargets_v1_1924
DrugGeneTargets_v1_1980
DrugGeneTargets_v1_2096
DrugGeneTargets_v1_2176
DrugGeneTargets_v1_2763
DrugGeneTargets_v1_3232
DrugGeneTargets_v1_3428
DrugGeneTargets_v1_3653
DrugGeneTargets_v1_3825
DrugGeneTargets_v1_4218
DrugGeneTargets_v1_4257
DrugGeneTargets_v1_4794
DrugGeneTargets_v1_4901
DrugGeneTargets_v1_5857
DrugGeneTargets_v1_5858
DrugGeneTargets_v1_5916
DrugGeneTargets_v1_6319
DrugGeneTargets_v1_526
DrugGeneTargets_v1_546
DrugGeneTargets_v1_1182
DrugGeneTargets_v1_1335
DrugGeneTargets_v1_1493
DrugGeneTargets_v1_1744
DrugGeneTargets_v1_1897
DrugGeneTargets_v1_1964
DrugGeneTargets_v1_2345
DrugGeneTargets_v1_2424
DrugGeneTargets_v1_3251
DrugGeneTargets_v1_3542
DrugGeneTargets_v1_5425
DrugGeneTargets_v1_6028
DrugGeneTargets_v1_1398
DrugGeneTargets_v1_3018
DrugGeneTargets_v1_5480
DrugGeneTargets_v1_5516
DrugGeneTargets_v1_2000
DrugGeneTargets_v1_2484
DrugGeneTargets_v1_5496
DrugGeneTargets_v1_6224
DrugGeneTargets_v1_4450
DrugGeneTargets_v1_4472
DrugGeneTargets_v1_340
DrugGeneTargets_v1_834
DrugGeneTargets_v1_1024
DrugGeneTargets_v1_1616
DrugGeneTargets_v1_2562
DrugGeneTargets_v1_4247
DrugGeneTargets_v1_6333
DrugGeneTargets_v1_830
DrugGeneTargets_v1_947
DrugGeneTargets_v1_1648
DrugGeneTargets_v1_2324
DrugGeneTargets_v1_2738
DrugGeneTargets_v1_2877
DrugGeneTargets_v1_3618
DrugGeneTargets_v1_4112
DrugGeneTargets_v1_4170
DrugGeneTargets_v1_4320
DrugGeneTargets_v1_4396
DrugGeneTargets_v1_4678
DrugGeneTargets_v1_700
DrugGeneTargets_v1_755
DrugGeneTargets_v1_1622
DrugGeneTargets_v1_2908
DrugGeneTargets_v1_3907
DrugGeneTargets_v1_4017
DrugGeneTargets_v1_5009
DrugGeneTargets_v1_6201
DrugGeneTargets_v1_2033
DrugGeneTargets_v1_2185
DrugGeneTargets_v1_2381
DrugGeneTargets_v1_3088
DrugGeneTargets_v1_3625
DrugGeneTargets_v1_3659
DrugGeneTargets_v1_3754
DrugGeneTargets_v1_4117
DrugGeneTargets_v1_4644
DrugGeneTargets_v1_4696
DrugGeneTargets_v1_5215
DrugGeneTargets_v1_6101
DrugGeneTargets_v1_739
DrugGeneTargets_v1_2184
DrugGeneTargets_v1_3967
DrugGeneTargets_v1_5018
DrugGeneTargets_v1_5147
DrugGeneTargets_v1_1460
DrugGeneTargets_v1_2545
DrugGeneTargets_v1_2705
DrugGeneTargets_v1_2775
DrugGeneTargets_v1_2805
DrugGeneTargets_v1_2982
DrugGeneTargets_v1_3129
DrugGeneTargets_v1_3333
DrugGeneTargets_v1_3438
DrugGeneTargets_v1_6294
DrugGeneTargets_v1_624
DrugGeneTargets_v1_1682
DrugGeneTargets_v1_2236
DrugGeneTargets_v1_3094
DrugGeneTargets_v1_3999
DrugGeneTargets_v1_4260
DrugGeneTargets_v1_1237
DrugGeneTargets_v1_3651
DrugGeneTargets_v1_5735
DrugGeneTargets_v1_2597
DrugGeneTargets_v1_4491
DrugGeneTargets_v1_5641
DrugGeneTargets_v1_1573
DrugGeneTargets_v1_2231
DrugGeneTargets_v1_3772
DrugGeneTargets_v1_4258
DrugGeneTargets_v1_4118
DrugGeneTargets_v1_4384
DrugGeneTargets_v1_330
DrugGeneTargets_v1_5759
DrugGeneTargets_v1_4500
DrugGeneTargets_v1_5507
DrugGeneTargets_v1_2446
DrugGeneTargets_v1_1583
DrugGeneTargets_v1_1637
DrugGeneTargets_v1_1703
DrugGeneTargets_v1_4495
DrugGeneTargets_v1_3856
DrugGeneTargets_v1_5281
DrugGeneTargets_v1_5122
DrugGeneTargets_v1_1723
DrugGeneTargets_v1_6001
DrugGeneTargets_v1_6378
DrugGeneTargets_v1_1170
DrugGeneTargets_v1_4167
DrugGeneTargets_v1_3002
DrugGeneTargets_v1_646
DrugGeneTargets_v1_3578
DrugGeneTargets_v1_449
DrugGeneTargets_v1_4032
DrugGeneTargets_v1_5610
DrugGeneTargets_v1_238
DrugGeneTargets_v1_958
DrugGeneTargets_v1_1668
DrugGeneTargets_v1_5571
DrugGeneTargets_v1_3309
DrugGeneTargets_v1_2206
DrugGeneTargets_v1_6079
DrugGeneTargets_v1_680
DrugGeneTargets_v1_5815
DrugGeneTargets_v1_3491
DrugGeneTargets_v1_5224
DrugGeneTargets_v1_169
DrugGeneTargets_v1_5407
DrugGeneTargets_v1_393
DrugGeneTargets_v1_6190
DrugGeneTargets_v1_5707
DrugGeneTargets_v1_6275
DrugGeneTargets_v1_1142
DrugGeneTargets_v1_3802
DrugGeneTargets_v1_6216
DrugGeneTargets_v1_2072
DrugGeneTargets_v1_2824
DrugGeneTargets_v1_74
DrugGeneTargets_v1_1613
DrugGeneTargets_v1_1080
DrugGeneTargets_v1_3495
DrugGeneTargets_v1_5821
DrugGeneTargets_v1_1732
DrugGeneTargets_v1_1733
DrugGeneTargets_v1_625
DrugGeneTargets_v1_2111
DrugGeneTargets_v1_2610
DrugGeneTargets_v1_2611
DrugGeneTargets_v1_4692
DrugGeneTargets_v1_5619
DrugGeneTargets_v1_4401
DrugGeneTargets_v1_4402
DrugGeneTargets_v1_4473
DrugGeneTargets_v1_28
DrugGeneTargets_v1_29
DrugGeneTargets_v1_573
DrugGeneTargets_v1_574
DrugGeneTargets_v1_932
DrugGeneTargets_v1_933
DrugGeneTargets_v1_2714
DrugGeneTargets_v1_2715
DrugGeneTargets_v1_3312
DrugGeneTargets_v1_3313
DrugGeneTargets_v1_3619
DrugGeneTargets_v1_3620
DrugGeneTargets_v1_3778
DrugGeneTargets_v1_3485
DrugGeneTargets_v1_3486
DrugGeneTargets_v1_4781
DrugGeneTargets_v1_4782
DrugGeneTargets_v1_1401
DrugGeneTargets_v1_4120
DrugGeneTargets_v1_3671
DrugGeneTargets_v1_3672
DrugGeneTargets_v1_5136
DrugGeneTargets_v1_5137
DrugGeneTargets_v1_1252
DrugGeneTargets_v1_1953
DrugGeneTargets_v1_3014
DrugGeneTargets_v1_2574
DrugGeneTargets_v1_2575
DrugGeneTargets_v1_4626
DrugGeneTargets_v1_4627
DrugGeneTargets_v1_305
DrugGeneTargets_v1_306
DrugGeneTargets_v1_5088
DrugGeneTargets_v1_1373
DrugGeneTargets_v1_6358
DrugGeneTargets_v1_2147
DrugGeneTargets_v1_4734
DrugGeneTargets_v1_1901
DrugGeneTargets_v1_864
DrugGeneTargets_v1_865
DrugGeneTargets_v1_3205
DrugGeneTargets_v1_4819
DrugGeneTargets_v1_61
DrugGeneTargets_v1_62
DrugGeneTargets_v1_5558
DrugGeneTargets_v1_1477
DrugGeneTargets_v1_5681
DrugGeneTargets_v1_4723
DrugGeneTargets_v1_4724
DrugGeneTargets_v1_4725
DrugGeneTargets_v1_3153
DrugGeneTargets_v1_5911
DrugGeneTargets_v1_5912
DrugGeneTargets_v1_5913
DrugGeneTargets_v1_5179
DrugGeneTargets_v1_5180
DrugGeneTargets_v1_5181
DrugGeneTargets_v1_344
DrugGeneTargets_v1_345
DrugGeneTargets_v1_1844
DrugGeneTargets_v1_1845
DrugGeneTargets_v1_3327
DrugGeneTargets_v1_3328
DrugGeneTargets_v1_5015
DrugGeneTargets_v1_5016
DrugGeneTargets_v1_2660
DrugGeneTargets_v1_2661
DrugGeneTargets_v1_3214
DrugGeneTargets_v1_2628
DrugGeneTargets_v1_6249
DrugGeneTargets_v1_5971
DrugGeneTargets_v1_363
DrugGeneTargets_v1_1965
DrugGeneTargets_v1_1966
DrugGeneTargets_v1_1967
DrugGeneTargets_v1_1968
DrugGeneTargets_v1_1969
DrugGeneTargets_v1_4431
DrugGeneTargets_v1_5087
DrugGeneTargets_v1_641
DrugGeneTargets_v1_5414
DrugGeneTargets_v1_5801
DrugGeneTargets_v1_6222
DrugGeneTargets_v1_186
DrugGeneTargets_v1_405
DrugGeneTargets_v1_753
DrugGeneTargets_v1_1646
DrugGeneTargets_v1_2067
DrugGeneTargets_v1_6013
DrugGeneTargets_v1_5238
DrugGeneTargets_v1_6096
DrugGeneTargets_v1_3443
DrugGeneTargets_v1_5922
DrugGeneTargets_v1_2652
DrugGeneTargets_v1_6315
DrugGeneTargets_v1_4545
DrugGeneTargets_v1_1225
DrugGeneTargets_v1_3782
DrugGeneTargets_v1_5728
DrugGeneTargets_v1_5756
DrugGeneTargets_v1_5757
DrugGeneTargets_v1_1084
DrugGeneTargets_v1_1085
DrugGeneTargets_v1_560
DrugGeneTargets_v1_4158
DrugGeneTargets_v1_2795
DrugGeneTargets_v1_1871
DrugGeneTargets_v1_2146",8/20/2024,Maya,,Pharmacology,,,,,,,,
Q72,When was Quazepam assigned a United States Adopted Name (USAN) and approved for use by the FDA?,Quazepam was assigned a USAN in 1976 and was approved for use by the FDA in 1985.,DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964765 DrugTargetsIndication121923_text_964743 DrugTargetsIndication121923_text_964755 DrugTargetsIndication121923_text_964759 DrugTargetsIndication121923_text_964735 DrugTargetsIndication121923_text_964762 DrugTargetsIndication121923_text_964760 DrugTargetsIndication121923_text_964742 DrugTargetsIndication121923_text_964758 DrugTargetsIndication121923_text_964752 DrugTargetsIndication121923_text_964740 DrugTargetsIndication121923_text_964744 DrugTargetsIndication121923_text_964763 DrugTargetsIndication121923_text_964734 DrugTargetsIndication121923_text_964746 DrugTargetsIndication121923_text_964748 DrugTargetsIndication121923_text_964754 DrugTargetsIndication121923_text_964739 DrugTargetsIndication121923_text_964749 DrugTargetsIndication121923_text_964757 DrugTargetsIndication121923_text_964761 DrugTargetsIndication121923_text_964750 DrugTargetsIndication121923_text_964745 DrugTargetsIndication121923_text_964751 DrugTargetsIndication121923_text_964741 DrugTargetsIndication121923_text_964736 DrugTargetsIndication121923_text_964737 DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964738 DrugTargetsIndication121923_text_964747 DrugTargetsIndication121923_text_964764,July 3th,Marzieh,,Drug meta,,,,,,,,
Q73,"For what condition is Quazepam indicated, and which Experimental Factor Ontology (EFO) and Medical Subject Headings (MeSH) terms are associated with it?","Quazepam is indicated for the treatment of insomnia, associated with the Experimental Factor Ontology (EFO) term EFO:0004698 and the Medical Subject Headings (MeSH) term Sleep Initiation and Maintenance Disorders (D007319).",DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964765 DrugTargetsIndication121923_text_964743 DrugTargetsIndication121923_text_964755 DrugTargetsIndication121923_text_964759 DrugTargetsIndication121923_text_964735 DrugTargetsIndication121923_text_964762 DrugTargetsIndication121923_text_964760 DrugTargetsIndication121923_text_964742 DrugTargetsIndication121923_text_964758 DrugTargetsIndication121923_text_964752 DrugTargetsIndication121923_text_964740 DrugTargetsIndication121923_text_964744 DrugTargetsIndication121923_text_964763 DrugTargetsIndication121923_text_964734 DrugTargetsIndication121923_text_964746 DrugTargetsIndication121923_text_964748 DrugTargetsIndication121923_text_964754 DrugTargetsIndication121923_text_964739 DrugTargetsIndication121923_text_964749 DrugTargetsIndication121923_text_964757 DrugTargetsIndication121923_text_964761 DrugTargetsIndication121923_text_964750 DrugTargetsIndication121923_text_964745 DrugTargetsIndication121923_text_964751 DrugTargetsIndication121923_text_964741 DrugTargetsIndication121923_text_964736 DrugTargetsIndication121923_text_964737 DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964738 DrugTargetsIndication121923_text_964747 DrugTargetsIndication121923_text_964764,July 3th,Marzieh,,Drug Disease relations,,,,,,,,
Q74,What are the trade names and synonyms associated with Quazepam?,"The trade name of this drug is Doral, and its synonyms are NSC-309702, Quazepam civ, SCH 16134, and SCH-16134.",DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964765 DrugTargetsIndication121923_text_964743 DrugTargetsIndication121923_text_964755 DrugTargetsIndication121923_text_964759 DrugTargetsIndication121923_text_964735 DrugTargetsIndication121923_text_964762 DrugTargetsIndication121923_text_964760 DrugTargetsIndication121923_text_964742 DrugTargetsIndication121923_text_964758 DrugTargetsIndication121923_text_964752 DrugTargetsIndication121923_text_964740 DrugTargetsIndication121923_text_964744 DrugTargetsIndication121923_text_964763 DrugTargetsIndication121923_text_964734 DrugTargetsIndication121923_text_964746 DrugTargetsIndication121923_text_964748 DrugTargetsIndication121923_text_964754 DrugTargetsIndication121923_text_964739 DrugTargetsIndication121923_text_964749 DrugTargetsIndication121923_text_964757 DrugTargetsIndication121923_text_964761 DrugTargetsIndication121923_text_964750 DrugTargetsIndication121923_text_964745 DrugTargetsIndication121923_text_964751 DrugTargetsIndication121923_text_964741 DrugTargetsIndication121923_text_964736 DrugTargetsIndication121923_text_964737 DrugTargetsIndication121923_text_964756 DrugTargetsIndication121923_text_964738 DrugTargetsIndication121923_text_964747 DrugTargetsIndication121923_text_964764,July 3th,Marzieh,,Drug meta,,,,,,,,
Q75,What was the first phosphate salt drug and when was it approved by the FDA? ,Histamine Phosphate was the first phosphate salt drug and was approved by the FDA 1939.  ,DrugGeneTargets_v2_2178,8/26/2024,Maya,,Drug forms; Drug Disease relations; Drug meta,,,,,,,,
Q76,How many investigational indications does Iratumumab have?,Iratumumab has 3 investigational indications but is not approved by the FDA for the treatment of any disease.,DrugGeneTargets_v1_2241,July 3th,Marzieh/Maya,,Drug meta,,,,,,,,
Q77,When was Sonidegib Phosphate assigned a United States assigned name (USAN)?,Sonidegib Phosphate was assigned a United States assigned name (USAN) in 2013.,DrugTargetsIndication121923_text_1072620 DrugTargetsIndication121923_text_1072622 DrugTargetsIndication121923_text_1072621,July 3th,Marzieh,,Drug meta,,,,,,,,
Q78,Can you describe the association between the SNCA gene and Parkinson's disease?,"The gene SNCA has 218 SNPs that are significantly associated with Parkinson's disease, here are the top 10: 
• rs356203        
•        b value=        0.2398
•        P-value=        3.01E-41
• rs356204        
•        b value=        0.2085
•        P-value=        2.87E-32
• rs189596        
•        b value=        0.2093
•        P-value=        4.29E-32
• rs356200        
•        b value=        0.2084
•        P-value=        5.61E-32
• rs356168        
•        b value=        0.2089
•        P-value=        8.41E-32
• rs2736990        
•        b value=        0.2089
•        P-value=        1.08E-31
• rs1372518        
•        b value=        -0.2334
•        P-value=        5.35E-29
• rs1372519        
•        b value=        -0.2279
•        P-value=        6.05E-28
• rs1372520        
•        b value=        -0.2267
•        P-value=        1.19E-27
• rs990085        
•        b value=        -0.2321
•        P-value=        2.25E-27","PDno23andme_full_gene_notext_1492093
PDno23andme_full_gene_notext_6805650
PDno23andme_full_gene_notext_7042578
PDno23andme_full_gene_notext_3240570
PDno23andme_full_gene_notext_2591502
PDno23andme_full_gene_notext_5819926
PDno23andme_full_gene_notext_2683188
PDno23andme_full_gene_notext_4965940
PDno23andme_full_gene_notext_4221061
PDno23andme_full_gene_notext_1776190
PDno23andme_full_gene_notext_5233185
PDno23andme_full_gene_notext_6922072
PDno23andme_full_gene_notext_3740399
PDno23andme_full_gene_notext_7549829
PDno23andme_full_gene_notext_3511837
PDno23andme_full_gene_notext_5450418
PDno23andme_full_gene_notext_3411033
PDno23andme_full_gene_notext_1336881
PDno23andme_full_gene_notext_723828
PDno23andme_full_gene_notext_3615409
PDno23andme_full_gene_notext_4404188
PDno23andme_full_gene_notext_3686644
PDno23andme_full_gene_notext_7165858
PDno23andme_full_gene_notext_6858182
PDno23andme_full_gene_notext_6139131
PDno23andme_full_gene_notext_5469680
PDno23andme_full_gene_notext_7671019
PDno23andme_full_gene_notext_1891942
PDno23andme_full_gene_notext_3945878
PDno23andme_full_gene_notext_5114632
PDno23andme_full_gene_notext_5792625
PDno23andme_full_gene_notext_4244890
PDno23andme_full_gene_notext_5699697
PDno23andme_full_gene_notext_2138953
PDno23andme_full_gene_notext_1458962
PDno23andme_full_gene_notext_3155638
PDno23andme_full_gene_notext_1141587
PDno23andme_full_gene_notext_2108200
PDno23andme_full_gene_notext_1610459
PDno23andme_full_gene_notext_6073657
PDno23andme_full_gene_notext_4967358
PDno23andme_full_gene_notext_3586376
PDno23andme_full_gene_notext_4186646
PDno23andme_full_gene_notext_6634203
PDno23andme_full_gene_notext_5980492
PDno23andme_full_gene_notext_754910
PDno23andme_full_gene_notext_2129391
PDno23andme_full_gene_notext_2898081
PDno23andme_full_gene_notext_2058618
PDno23andme_full_gene_notext_1185479
PDno23andme_full_gene_notext_3083469
PDno23andme_full_gene_notext_5894039
PDno23andme_full_gene_notext_6763690
PDno23andme_full_gene_notext_6248628
PDno23andme_full_gene_notext_3234342
PDno23andme_full_gene_notext_3340733
PDno23andme_full_gene_notext_5788290
PDno23andme_full_gene_notext_912478
PDno23andme_full_gene_notext_566908
PDno23andme_full_gene_notext_7632805
PDno23andme_full_gene_notext_7098783
PDno23andme_full_gene_notext_5064348
PDno23andme_full_gene_notext_1596560
PDno23andme_full_gene_notext_7552804
PDno23andme_full_gene_notext_5732064
PDno23andme_full_gene_notext_4096142
PDno23andme_full_gene_notext_2559478
PDno23andme_full_gene_notext_248194
PDno23andme_full_gene_notext_5219548
PDno23andme_full_gene_notext_6055755
PDno23andme_full_gene_notext_2434106
PDno23andme_full_gene_notext_634001
PDno23andme_full_gene_notext_981056
PDno23andme_full_gene_notext_5963569
PDno23andme_full_gene_notext_3502315
PDno23andme_full_gene_notext_1864400
PDno23andme_full_gene_notext_4828268
PDno23andme_full_gene_notext_5731359
PDno23andme_full_gene_notext_7208332
PDno23andme_full_gene_notext_5635473
PDno23andme_full_gene_notext_5488337
PDno23andme_full_gene_notext_2924847
PDno23andme_full_gene_notext_601914
PDno23andme_full_gene_notext_2754296
PDno23andme_full_gene_notext_4620113
PDno23andme_full_gene_notext_4942372
PDno23andme_full_gene_notext_4354202
PDno23andme_full_gene_notext_6271047
PDno23andme_full_gene_notext_182797
PDno23andme_full_gene_notext_3009514
PDno23andme_full_gene_notext_1626528
PDno23andme_full_gene_notext_207585
PDno23andme_full_gene_notext_5649369
PDno23andme_full_gene_notext_5545002
PDno23andme_full_gene_notext_1992866
PDno23andme_full_gene_notext_1006993
PDno23andme_full_gene_notext_3161418
PDno23andme_full_gene_notext_6919182
PDno23andme_full_gene_notext_1316234
PDno23andme_full_gene_notext_1149710
PDno23andme_full_gene_notext_3567663
PDno23andme_full_gene_notext_6938716
PDno23andme_full_gene_notext_2236779
PDno23andme_full_gene_notext_3700367
PDno23andme_full_gene_notext_1922551
PDno23andme_full_gene_notext_4705107
PDno23andme_full_gene_notext_7462100
PDno23andme_full_gene_notext_2794178
PDno23andme_full_gene_notext_4820576
PDno23andme_full_gene_notext_5311124
PDno23andme_full_gene_notext_5045149
PDno23andme_full_gene_notext_2985421
PDno23andme_full_gene_notext_1029104
PDno23andme_full_gene_notext_201927
PDno23andme_full_gene_notext_4957143
PDno23andme_full_gene_notext_3373040
PDno23andme_full_gene_notext_149885
PDno23andme_full_gene_notext_4926331
PDno23andme_full_gene_notext_3362781
PDno23andme_full_gene_notext_5222506
PDno23andme_full_gene_notext_6447647
PDno23andme_full_gene_notext_575618
PDno23andme_full_gene_notext_270859
PDno23andme_full_gene_notext_759560
PDno23andme_full_gene_notext_4830172
PDno23andme_full_gene_notext_54325
PDno23andme_full_gene_notext_2287661
PDno23andme_full_gene_notext_7174594
PDno23andme_full_gene_notext_4499852
PDno23andme_full_gene_notext_3033563
PDno23andme_full_gene_notext_3377310
PDno23andme_full_gene_notext_5891586
PDno23andme_full_gene_notext_6443329
PDno23andme_full_gene_notext_2006830
PDno23andme_full_gene_notext_4432820
PDno23andme_full_gene_notext_4275596
PDno23andme_full_gene_notext_4703416
PDno23andme_full_gene_notext_3341654
PDno23andme_full_gene_notext_2270096
PDno23andme_full_gene_notext_4068602
PDno23andme_full_gene_notext_2323766
PDno23andme_full_gene_notext_7472287
PDno23andme_full_gene_notext_6132985
PDno23andme_full_gene_notext_4448730
PDno23andme_full_gene_notext_6186797
PDno23andme_full_gene_notext_3412198
PDno23andme_full_gene_notext_3797845
PDno23andme_full_gene_notext_3922394
PDno23andme_full_gene_notext_625911
PDno23andme_full_gene_notext_5404279
PDno23andme_full_gene_notext_6705975
PDno23andme_full_gene_notext_2439296
PDno23andme_full_gene_notext_3307812
PDno23andme_full_gene_notext_1517619
PDno23andme_full_gene_notext_3451038
PDno23andme_full_gene_notext_1351675
PDno23andme_full_gene_notext_746909
PDno23andme_full_gene_notext_5303607
PDno23andme_full_gene_notext_6638156
PDno23andme_full_gene_notext_3616937
PDno23andme_full_gene_notext_3872692
PDno23andme_full_gene_notext_1902475
PDno23andme_full_gene_notext_2735905
PDno23andme_full_gene_notext_2511278
PDno23andme_full_gene_notext_6874555
PDno23andme_full_gene_notext_7458107
PDno23andme_full_gene_notext_2751323
PDno23andme_full_gene_notext_729904
PDno23andme_full_gene_notext_2459080
PDno23andme_full_gene_notext_6527320
PDno23andme_full_gene_notext_1158538
PDno23andme_full_gene_notext_6731021
PDno23andme_full_gene_notext_452250
PDno23andme_full_gene_notext_4411182
PDno23andme_full_gene_notext_3490709
PDno23andme_full_gene_notext_2412673
PDno23andme_full_gene_notext_2915505
PDno23andme_full_gene_notext_1290821
PDno23andme_full_gene_notext_2931296
PDno23andme_full_gene_notext_6158117
PDno23andme_full_gene_notext_149675
PDno23andme_full_gene_notext_4974861
PDno23andme_full_gene_notext_2788253
PDno23andme_full_gene_notext_3116556
PDno23andme_full_gene_notext_3386184
PDno23andme_full_gene_notext_3992725
PDno23andme_full_gene_notext_5253781
PDno23andme_full_gene_notext_6917557
PDno23andme_full_gene_notext_5601715
PDno23andme_full_gene_notext_2439217
PDno23andme_full_gene_notext_6805110
PDno23andme_full_gene_notext_6366979
PDno23andme_full_gene_notext_5562638
PDno23andme_full_gene_notext_2744957
PDno23andme_full_gene_notext_2915037
PDno23andme_full_gene_notext_1553385
PDno23andme_full_gene_notext_7442171
PDno23andme_full_gene_notext_2357321
PDno23andme_full_gene_notext_7182535
PDno23andme_full_gene_notext_6568546
PDno23andme_full_gene_notext_1373016
PDno23andme_full_gene_notext_5746066
PDno23andme_full_gene_notext_679880
PDno23andme_full_gene_notext_4255719
PDno23andme_full_gene_notext_3214763
PDno23andme_full_gene_notext_5732271
PDno23andme_full_gene_notext_6831032
PDno23andme_full_gene_notext_2261620
PDno23andme_full_gene_notext_2006269
PDno23andme_full_gene_notext_4477476
PDno23andme_full_gene_notext_1945781
PDno23andme_full_gene_notext_3347265
PDno23andme_full_gene_notext_140491
PDno23andme_full_gene_notext_2494451
PDno23andme_full_gene_notext_7478
PDno23andme_full_gene_notext_4544624
PDno23andme_full_gene_notext_1221032
PDno23andme_full_gene_notext_701322",7/30/2024,Maya,,Gene disease relations ,,,,,,,,
Q79,Which tissues express genes with SNPs that are associated with PD? ,"Out of the 22 tissues tested, 21 expressed genes with SNPs that are significantly associated with Parkinson's Disease (PD). The tissue expressing genes with the highest number of significant SNPs was the whole brain, with 220 significant SNPs. The spinal cord had the highest proportion of significant SNPs relative to the total SNPs, with a proportional significance of 0.002.",All rows in PDno23andme_full_gene_notext,7/30/2024,Maya,,Tissue; Snp disease relations ,,,,,,,,
Q80,What is the patent number associated with Sonidegib Phosphate?,"There are 3 patent numbers associated with the drug Sonidegib Phosphate; 8178563, 10266523, and 8063043.","DrugTargetsIndication121923_text_1072620 
DrugTargetsIndication121923_text_1072622 
DrugTargetsIndication121923_text_1072621 ",7/30/2024,Marzieh/Maya,,Drug meta,,,,,,,,
Q81,Which morphinan scaffold derived medications have been modified for extended-release (ER) or sustained-release (SR) using Polistirex?,"Hydrocodone, Codeine, and Dextromethorphan are all morphinan scaffold derived medications that have modified formulations using Polistirex to extend their release time, creating extended-release (ER) or sustained-release (SR) versions of these medications.","DrugGeneTargets_v1_3604
DrugGeneTargets_v1_3605
DrugGeneTargets_v1_2492
DrugGeneTargets_v1_494",8/12/2024,Maya,,Drug forms; Pharmacology,,,,,,,,
Q82,,,,,,,,,,,,,,,
Q83,,,,,,,,,,,,,,,
Q84,,,,,,,,,,,,,,,
Q85,,,,,,,,,,,,,,,
Q86,,,,,,,,,,,,,,,
Q87,,,,,,,,,,,,,,,
Q88,,,,,,,,,,,,,,,
Q89,,,,,,,,,,,,,,,
Q90,,,,,,,,,,,,,,,
Q91,,,,,,,,,,,,,,,
Q92,,,,,,,,,,,,,,,
Q93,,,,,,,,,,,,,,,
Q94,,,,,,,,,,,,,,,
Q95,,,,,,,,,,,,,,,
Q96,,,,,,,,,,,,,,,
Q97,,,,,,,,,,,,,,,
Q98,,,,,,,,,,,,,,,
Q99,,,,,,,,,,,,,,,
Q100,,,,,,,,,,,,,,,
Q101,,,,,,,,,,,,,,,
Q102,,,,,,,,,,,,,,,
Q103,,,,,,,,,,,,,,,
Q104,,,,,,,,,,,,,,,
Q105,,,,,,,,,,,,,,,